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Abstract
From the late 1980s, the automation of sequencing techniques and the computer
spread gave rise to a flourishing number of new molecular structures and sequences
and to proliferation of new databases in which to store them. Here are presented
three computational approaches able to analyse the massive amount of publicly
avalilable data in order to answer to important biological questions.
The first strategy studies the incorrect assignment of the first AUG codon in
a messenger RNA (mRNA), due to the incomplete determination of its 5′ end
sequence. An extension of the mRNA 5′ coding region was identified in 477 in
human loci, out of all human known mRNAs analysed, using an automated ex-
pressed sequence tag (EST)-based approach. Proof-of-concept confirmation was
obtained by in vitro cloning and sequencing for GNB2L1, QARS and TDP2 and the
consequences for the functional studies are discussed.
The second approach analyses the codon bias, the phenomenon in which distinct
synonymous codons are used with different frequencies, and, following integration
with a gene expression profile, estimates the total number of codons present across
all the expressed mRNAs (named here "codonome value") in a given biological
condition. Systematic analyses across different pathological and normal human
tissues and multiple species shows a surprisingly tight correlation between the codon
bias and the codonome bias.
The third approach is useful to studies the expression of human autism spectrum
disorder (ASD) implicated genes. ASD implicated genes sharing microRNA re-
sponse elements (MREs) for the same microRNA are co-expressed in brain samples
from healthy and ASD affected individuals. The different expression of a recently
identified long non coding RNA which have four MREs for the same microRNA
could disrupt the equilibrium in this network, but further analyses and experiments
are needed.
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Chapter 1
Introduction
1.1 Computational Biology
The story of Computational Biology started in the mid 1940s, when Fred Sanger
published his first work on insulin [Sanger, 1945]. He used chemical and enzymatic
experiments to fragment the protein and to deduce from the amino acid sequence
of the fragments, the order of the amino acid in the intact protein. This led to the
complete primary structure of bovine, ovine and porcine insulin ten years later [e.g.
Sanger et al., 1955; Ryle et al., 1955; Brown et al., 1955]. It was the first time that
the order of amino acids of a protein was determined. Many years later the final
amino acid sequence of the first enzyme, the ribonuclease, was published [Smyth et
al., 1963]. Consequently, the sequence of many other proteins was soon deduced.
Margaret Dayhoff was the first to appreciate the importance of databases, the utility
of organising biological sequences and the value of sequence comparative analysis.
She began to collect all available protein sequences in order to facilitate her and
others researches and pulished them in book form, the "Atlas of Protein Sequence
and Structure" [Dayhoff et al., 1965]. Consequently, the advent of automated
peptide sequencers increased the rate of sequence determination considerably. The
numbers of deduced protein structures grew accordingly and it became soon neces-
sary to develop a system in order to collect, correlate and interpret this significant
information. The Cambrige Structural Database, a repository of small-molecule
crystal structures, is one of the oldest dabasases being established in 1965. The
common belief among scientists was that the collective use of data would lead to the
discovery of new knowledge which goes beyond the results yielded by individual
experiments [Kennard, 1997]. Many databases were thus established, among the
others the Protein Data Bank (PDB), in 1971, in order to collect protein coordinate
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data [Attwood et al., 2011].
Despite the progresses in the sequence and structure determination of proteins,
sequencing nucleic acids was still problematic, due to issues related to their greater
size and to the difficulties during purification. In 1977, Sanger developed a technol-
ogy (now known as the "Sanger method") that made possible to work with longer
nucleotide fragments [Sanger et al., 1977], giving origin to the field of reverse
genetics. This allowed the completion of the bacteriophage phiX174, the human
mitocondrial DNA and the lambda bacteriophage genomes sequencing [Sanger et
al., 1978; Anderson et al., 1981; Sanger et al., 1982] and brought cloning and se-
quencing into any laboratory worldwide. As well as happened many years ago for
proteins, with the enormous increase in the rate of sequencing DNA fragments, a
large computerised database of sequences became essential for research in molecu-
lar biology and several groups worldwide were engaged in the collection of nucleic
acid sequences. This was also the time when there was the computer hardware
revolution; thus tool needed to store, search and analyse new data developed along-
side the tools necessary to generate the data [Smith, 1990]. In 1980, the first in-
ternationally supported resource for nucleotide sequence data was established by
the European Molecular Biology Laboratory (EMBL) at Heidelberg (Germany),
with its first release in April 1982. The EMBL Data Library goals were to make
nucleic acid sequence data publicly available in the international molecular biology
community, to encourage standardisation and free exchange of data and also to
provide a European focus for computational and biological data service [Hamm
and Cameron, 1986]. Meanwhile the necessity of creating an international nucleic
acid sequence repository emerged also out of Europe, giving birth to GenBank,
with its first release in December 1982 [Benson et al., 1990]. From the beginning,
GenBank and the EMBL Data Library evolved in close collaboration. They were
distributed at first on magnetic tape and then on CD-ROM to anyone interested,
free of charge, in order to promote scientific progress. From 1986 onwards, they
started to collaborate also with the DNA Data Bank of Japan, adopting common
data-entry standards and data-exange protocol in order to improve data quality and
to manage the annotation of the exponential growing entries more effectively; they
are currently keeping pace with the literature [Attwood et al., 2011].
The late 1980s and early 1990s were fertile years thanks to the automation of
sequencing techniques and to the computer spread. This period of fervent activity
gave rise to a flourishing number of new molecular structures and sequences and to
proliferation of new databases in which to store them. Among others, in 1991 was
published a method to rapidly obtain partial RNA sequences [Adams et al., 1991].
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The RNA, extracted from various tissues, is converted in cDNA (complementary
DNA) by the reverse transcriptase and cloned using cDNA libraries. Then each
bacterial clone, containing the partial cDNA sequence complementary to the RNA
expressed in the tissue from which it was extracted, is sequenced with an automated
method. The obtained sequences are called expressed sequence tags (EST) and are
collected in the dbEST database, which represent an important resource in diverse
biological research fields [Boguski et al., 1993]. This unprecedented burst of se-
quencing activity yielded the first complete sequenced genome: the Haemophilus
influenzae genome [Fleischmann et al., 1995], followed by a flourishing of other
organism genome reports, to the human genome [Lander et al., 2001; Venter et al.,
2001; International Human Genome Sequencing Consortium, 2004]. Together with
these activities came the development of numerous databases to store and display
the emerging genomic data, e.g. Ensembl [http://www.ensembl.org/; Hubbard et
al., 2002], the Map Viewer at the National Center for Biotechnology Informa-
tion (NCBI) [http://www.ncbi.nlm.nih.gov/mapview/; Wheeler et al., 2005] and the
University of California at Santa Cruz (UCSC) Genome Browser [http://genome-
euro.ucsc.edu/cgi-bin/hgGateway; Kent et al., 2002]. They became the main sources
for information about specific genes and encoded polypeptides, and the starting
point for further experimentation. The term "bioinformatics" appeared in those
years to indicate the research, development, or application of computational tools
and approaches useful to solve problems related to management and analysis of
biological data [Biomedical Information Science and Technology Consortium Def-
inition Committee, released on July 17, 2000]. Therefore, algorithms to search
these databases became a necessity and this was the time that came the Basic Local
Alignment Search Tool, BLAST [Altschul et al., 1997]; this offered an extended
tool-set to apply any kind of sequence database search, and is still the most widely
used tool in computational biology and still in continuous development [Camacho
et al., 2009]. The success of BLAST led to a number of more specialised sequence
search methods, such as PSI-BLAST, PHI-BLAST and BLAT (BLAST-like Align-
ment Tool). Aside from these very popular database search tools, many other
sequence, annotation and expression analysis tools were developed for a broad
range of applications: e.g., for pattern recognition, for protein and RNA secondary
structure prediction, for microarray data analysis and for proteome and genome an-
notation [Attwood et al., 2011]. The public availabilty of data is of an unestimated
valour, because starting from the sequence comparison, without any laboratory
experiment, is possible to answer to important biological questions. The expres-
sion in silico, by analogy with in vivo and in vitro experiments, is usually used to
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refer to this kind of approach. In this work we will see how the vast amount of
public available data and the development of new computational tool to analyse it
are useful to study the structure and the expression of human genes.
1.2 Human genes
A gene is the basic physical and functional unit of heredity. It is a sequence of
DNA converted into a strand of so-called messenger RNA (mRNA) during the
process called transcription. An mRNA could be used as the basis for building its
associated molecule called protein [Pearson, 2006]. Briefly, a tipical human coding
mRNA structure include a coding region (CDS, coding DNA sequence) read into the
ribosome by the transfer RNA three nucleotides at time. There are 64 combinations
of three nucleotides, called codons, and each codon encode for a specific amino
acid (20 in all) according to the genetic code rules (Fig. 1.1). The first codon of
the coding region is the translation initiation codon (AUG), which encode for a
methionine (M); the last codon is one of the three stop codons (UAA, UAG, UGA),
which does not specify for any amino acid and terminate the protein synthesis. The
coding region is surrounded by two non coding regions: the 5′ UTR (untranslated
region) and the 3′ UTR, surrounded in turn by the 7-methyl guanosine cap and the
poly-adenine tail (poly-A), respectively (Fig. 1.2) [Alberts et al., 1994].
The Human Genome Project has estimated that humans have between 20,000
and 25,000 protein coding genes [International Human Genome Sequencing Con-
sortium, 2004]. This relatively "low" number correlated with the fact that two-thirds
of the human genome are pervasively transcribe, means that the other expressed
genes encode for non coding RNAs (ncRNAs). ncRNAs are generally divided
into two classes based on an arbitrary length cut-off of 200 nucleotides. Those
under 200 nucleotides are usually referred to as short/small ncRNAs, including the
microRNAs. microRNAs are generally 21 to 25 nucleotides long and are integral
components of RNA-induced silencing complex (RISC); they recognise partially
complementary target mRNAs, termed microRNA response elements (MREs), to
induce translational repression or mRNA degradation. ncRNAs greater than 200
nucleotides are known as long non coding RNAs (lncRNAs). The lncRNA intrinsic
nucleic acid nature confers the ability to function as ligands for proteins and to bind
specific RNA or DNA target sites in order to regulate gene espression [Fatica and
Bozzoni, 2014]. In the following paragraphs, three aspects regarding the structure
and expression of human genes studied in this thesis will be introduced.
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Figure 1.1: The genetic code. Sets of three nucleotides (codons) in an mRNA
molecule are translated into amino acids in the course of protein synthesis according
to the rules shown.
Introduction 6
Figure 1.2: The structure of an mRNA. On the left the 7-methyl guanosine cap
(5′ cap), which is part of the structure recognised by the small ribosomal subunit
(in red). The A sequence is the poly-A tail. Light blue: the coding region with
its initiation codon AUG. Dark green: the stop codon. Dark blue: the 5′ UTR
(untranslated region) and the 3′ UTR.
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1.3 mRNA 5′ coding sequence
The term "5′ end mRNA artifact" refers to the incorrect assignment of the first AUG
codon in an mRNA, due to the incomplete determination of its 5′ end sequence
[Casadei et al., 2003]. Since the 1970s, the amino acid sequence of gene products
has been routinely deduced from the nucleotide sequence of the relative cloned
cDNA, according to rules for recognition of the start codon (first-AUG rule, optimal
sequence context) and the genetic code [Kozak, 2002]. All standard methods for
the cDNA cloning are affected by a potential inability to effectively clone the 5′
region of the mRNA [Sambrook and Russel, 2001]. This is due to the reverse
transcriptase failure to extend first-strand cDNA along the full length of the mRNA
template toward its 5′ end [Sambrook and Russel, 2001]. These incomplete clone
sequences consequently lead to the incorrect assignment of the first AUG codon.
The identification of a more complete mRNA 5′ end could reveal an additional
upstream AUG, in-frame with the previously determined one, thus extending the
predicted amino terminus sequence of the product and avoiding subsequent relevant
errors in the experimental study of the relative cDNA [Casadei et al., 2003]. An
incomplete amino terminus sequence could therefore lead to errors in in vitro ex-
pression of proteins and in the further functional assays.
Methods to determine the full-length mRNA sequence on a large scale have
been developed, such as 5′ cap trapping [Carninci et al., 1996], cap analysis of
gene expression (CAGE) [Kodzius et al., 2006], systematic empirical annotation
of a set of transcript products by 5′ rapid amplification of cDNA ends (RACE)
and high-density resolution tiling arrays [Denoeud et al., 2007]. However, they are
experimentally labor-intensive and they have not been widely applied in comparison
with the standard EST approach for fast characterisation of cDNAs [Adams et al.,
1991; Boguski et al., 1993].
An easy and efficient computational approach to revise all the known mRNA
sequences could be to compare all mRNA sequences with all EST sequences, both
publicly available on the relative database (RefSeq and dbEST, respectively) and
thus find EST sequences matching an mRNA 5′ end and extending it upstream. A
previous manual analysis confirmed the utility of this approach, identifying sixty
putative incomplete mRNAs out of the 109 human chromosome 21 protein-coding
genes considered and cloning five of them [Casadei et al., 2003]. The success of this
approach encouraged the authors to develop a piece of software ("5'_ORF_Extender"
software) in order to automate the steps that were previously performed manually.
They applied this software to the Danio rerio (zebrafish) genome and identified a
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putative extended mRNA 5′ end in the 3.3% of mRNA analysed, experimentally
confirming three example cases [Frabetti et al., 2007]. However, it proved difficult
to simply transfer the method used for D. rerio to Homo sapiens, due to the much
larger size and complexity of RNA and EST sequence databases as well as the
sequence analysis results file and a fully revised computational biology strategy
should be adopted.
1.4 Codon bias
Codon bias is the well-known phenomenon in which distinct synonymous codons
(different codons encoding the same amino acid) are used with different frequencies
(reviewed in [Hershberg and Petrov, 2008]). This has been observed in species from
all taxa. The codons that are used more frequently are also referred to as preferred
codons or "optimal codons" [Ikemura, 1981]. Previously, optimal and non-optimal
codons for each amino acid had been shown to differ between species [Grantham et
al., 1980], in particular between distantly related species.
Codon bias can be explained by two hypotheses: the mutational (or neutral)
explanation and the selectionist (or natural selection) explanation [Plotkin and Kudla,
2011]. According to the mutational explanation, codon bias originates from basal
mutational processes, which cause neither advantage nor damage. The selectionist
explanation asserts that synonymous mutations influence the fitness of an organism,
and can thus be promoted (or repressed) throughout evolution. These two types of
mechanisms are not mutually exclusive, and both are useful to understanding the
phenomenon within and between species. In particular, the latter explanation is
typically cited to explain variation in codon usage across a genome or across a gene
[Plotkin and Kudla, 2011].
In eukaryotic genes, the most frequently used codons have a bigger content
of G+C at the third codon position [Ikemura, 1985], especially in human genes,
according to the mutational (or neutral) explanation of the intra-genomic hetero-
geneity of the human genome [Sueoka and Kawanishi, 2000]. Preferred codons
also vary between genes of the same organism: expressed genes have a codon usage
pattern, different from poorly expressed genes, optimised to increase translational
efficiency [Ikemura, 1985] and to minimise the cost of nonsense errors during
protein translation [Gilchrist et al., 2009]. For example, optimal codons are recog-
nised by more abundant transfer RNA molecules in several unicellular organisms
[Kanaya et al., 1999] and in several eukaryotes [Kanaya et al., 2001]. These
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findings support the selectionist explanation (natural selection).
Intriguingly, Plotkin et al. [Plotkin et al., 2004] studied the role of codon usage
between tissue-specific human genes. Comparing testis- to uterus-specific genes
and brain- to liver-specific genes, they reported a characteristic codon usage in
genes expressed in one tissue as compared to those expressed in another. Other
comparisons (e.g. liver versus uterus) do not exhibit any significantly different
codon usage. However, the authors suggested that codon bias might optimise trans-
lation of tissue-specific genes. Furthermore Sémon et al. [Sémon et al., 2006],
analysing 2,126 human tissue-specific genes expressed in 18 different tissues, found
that the difference in synonymous codon usage between tissue-specific genes ex-
pressed in different tissues is significant, but weak, as the intra-tissue variability of
synonymous codon usage is much smaller than the inter-tissue variability. Addition-
ally, these authors correlated the synonymous codon usage variability to inter-gene
G+C content at the third position differences, also affecting introns and intergenic
regions, due to the isochore scale variation of substitution patterns [Sémon et al.,
2006].
At present several indexes are used to analyse codon bias, e.g. "Fop" [Ikemura,
1981], "CAI" [Sharp and Li, 1987], "E-CAI" [Puigbò et al., 2008], "CBI" [Bennetzen
and Hall, 1982], "Nc" [Wright, 1990], "G+C content of the third codon position"
[Sueoka and Kawanishi et al., 2000]. Several softwares for calculating these indexes
are freely available on the internet (e.g. CodonW, Correspondence Analysis of
Codon Usage, http://codonw.sourceforge.net/; JCat, Java Codon Adaptation Tool,
http://www.jcat.de/Introduction.jsp; INCA, http://bioinfo.hr/research/inca/).
Codon bias is usually related to the genome at the level of genome sequence and
noone has so far wondered if the proportion of used codons could vary during the
expression of a whole transcriptome. To determine the actual pool of codons borne
by all the mRNAs in the cell, the codon bias of each mRNA could be multiplied
by the relative estimated number of molecules of that mRNA in the transcriptome.
This could be done using once again the publicly available databases collecting
the mRNA sequences and the expression experiments data, such as microarray
data, in order to search for relationships between codon usage at the genome and
transcriptome levels.
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1.5 ASD implicated genes
Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder; it is
associated with impairments in social interaction and communications and with
repetitive and stereotyped patterns of behaviour, interests and activities and males
are affected four times more than female [Klauck, 2006]. Reviewing seven twin
studies emerged that ASD has a substantial genetic component, with median val-
ues for concordance rates of 76-88% in monozygotic twin in contrast to 0-31%
in dizygotic twins and an estimated heritability of 60-90% [Ronald and Hoekstra,
2011]. Extensive efforts went into identifying specific genetic causes and hundreds
of ASD susceptibility loci, candidate gene mutations and chromosomal abnormal-
ities have been studied [Betancur 2011]. An important study recently identified
MSNP1AS, a long non coding RNA which maps within a GWAS (genome-wide
association study) significant genetic marker for increased ASD risk [Kerin et al.,
2012; Wang et al., 2009]. MSNP1AS is encoded by the antisense strand of a MSN
pseudogene in human chromosome 5 (Fig. 1.3); MSN, the moesin gene, is located
on the X chromosome and encodes a protein that plays a role in axon and dendrite
development.
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Figure 1.3: MSNP1AS maps within the chromosome 5p14.1 GWAS significant
genetic marker for increased ASD risk. A. ASD-associated markers on chromosome
5p14.1 [adapted from Wang et al., 2009]. B. A 4 kilo bases (kb) RNA transcribed
from 5p14.1, as indicated by ESTs and RNA localisation (from the genome-wide
ENCODE tiling aray project). C. The plus strand of the 4 kb 5p14.1 region is
the MSNP1. The minus strand produces a non coding 3.9 kb RNA, designated
MSNP1AS [Kerin et al., 2012].
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Kerin et al. found a strongly increased MSNP1AS expression in post mortem
brain samples from individuals with ASD compared to those without; these higher
levels correlate with the presence of the genetic marker for increased ASD risk.
Furthermore the authors showed that MSN expression is also increased in post
mortem brain samples from ASD affected individuals compared to controls and
that MSNP1AS can bind MSN transcript in human neuronal cell line. Whether
MSNP1AS higher expression can down-regulate MSN protein has not been con-
firmed yet, because MSN level in brain samples from ASD affected individuals does
not change compared to controls [Kerin et al., 2012]. An alternative explanation
about how MSNP1AS could contribute to disease could be found according to the
mechanism of competing endogenous RNAs (ceRNAs) [Salmena et al., 2011].
Recent publications have shown that endogenous transcripts sharing MREs for the
same microRNA can influence the expression level of each other through com-
petitive microRNA binding: the decreased expression of one targeted transcript
increases the concentration of free microRNAs that can bind the other targeted tran-
script and consequentely suppresses its expression; vice versa the overexpression of
one targeted transcript leads to a decrease of available microRNAs that can bind the
other targeted transcript, thereby increasing its expression [Marques et al., 2011].
The ceRNA network contain both coding and non conding transcripts, indeed many
of protein coding genes are densely covered in MREs [Friedman et al., 2009] and
microRNAs also regulate lncRNAs. A network involving a long non coding RNA
in muscle differentiation by functioning as a ceRNA has already been described
[Cesana et al., 2011]. As MSNP1AS has four MREs for a microRNA (miR-ASD,
unpublished data), the overexpression of MSNP1AS observed in ASD affected in-
dividuals and with the risk genotype could reduce the concentration of miR-ASD,
increasing the expression of other targeted transcripts that could be ASD implicated
transcripts. This could be tested identifying MREs in ASD implicated genes and
confirming that MSNP1AS and ASD implicated genes are co-expressed in the same
network: a higher expression of MSNP1AS should lead to a higher expression of
ASD implicated genes.
Chapter 2
Aim of the thesis
2.1 Systematic analysis of the humanmRNA 5′ coding
sequences
The aim of the first section of this work was to perform a systematic identification
of coding regions at the 5′ end of all human known mRNAs. The identification
of a more complete mRNA 5′ end could reveal an additional upstream AUG (in-
frame with the previously determined one) thus extending the predicted amino
terminus sequence of the product and avoiding subsequent relevant errors in the
experimental study of the relative cDNA. The 5'_ORF_Extender software parses
and makes calculations on RefSeq (http://www.ncbi.nlm.nih.gov/RefSeq/) and EST
database sequences. This is done following the import of BLAT genome alignment
data for human mRNAs and ESTs, in order to determine a list of genes with an
incompletely described mRNA 5′ coding sequence. Due to the much larger size and
complexity of RNA and EST sequence databases as well as the sequence analysis
results file, the algorithm, previously described for D. rerio [Frabetti et al., 2007],
has been completely revised and improved for H. sapiens analysis.
As a proof-of-concept, the EST-based models has been experimentally con-
firmed by in vitro cloning and sequencing of RNA 5′ coding region sequence exten-
sion for GNB2L1, QARS and TDP2 human genes.
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2.2 Relationship between codon bias and expressed
RNA codons
The second part of this work was aimed to study the correlation between the codon
bias (phenomenon in which distinct synonymous codons are used with different
frequencies) and the number of codons present across all the expressed mRNAs,
here called "codonome". Here we define the "codonome value" as the total number
of codons (n) present across all the transcriptome mRNAs each expressed at a
certain level (x) in a given biological condition (cv = ∑(n × x) for the mRNAs
pool). The innovative "CODONOME" software has been developed to calculate the
frequency of each codon in any reference (RefSeq) mRNA sequence and, following
integration with a profile of gene expression values, to estimate the actual frequency
of each codon in the mRNA pool derived from a specific tissue of a given organism.
In addition, to investigate a possible cell adaptation aimed to optimize the trans-
lation process, these frequencies have been grouped by encoded amino acid, each
being related to its specific aminoacyl-tRNA synthetase (aaRS), to determine whether
some relationships exist between codon usage and aaRS mRNA expression level, a
still unexplored field. Gene expression values for a certain condition were obtained
from independent transcriptome datasets available in the Gene Expression Omnibus
(GEO) database [Barret and Edgar, 2006; Barret et al., 2009] following intra- and
inter-sample normalization using TRAM software [Lenzi et al., 2011].
A systematic analysis was performed varying the tissue examined within human
species, testing a normal tissue, a pathological condition with a general disturbance
of gene expression, i.e. the aneuploid blast from Down Syndrome (DS)-related
acute megakaryoblastic leukemia (AMKL), and an extremely differentiated tissue
with a remarkable expression preponderance of a very small number of proteins
(human circulating blood erythrocytes samples) and investigating a pool of repre-
sentative species from bacteria to humans. Then the codonome values was also
determined in Danio rerio), (Caenorhabditis elegans, Saccharomyces cerevisiae
and Escherichia coli) in order to search for general laws governing the structure
of the codonome.
The significance of the correlation coefficients was determined in each test for:
the per mil frequencies of codons (codon bias) vs. the per mil frequencies of
the codons number multiplied by expression value (codonome bias); the per mil
frequencies of codons (codon bias) grouped by aaRS vs. the aaRS expression val-
ues, and the per mil frequencies of the codons number multiplied by expression
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value (codonome bias) grouped by aaRS vs. the aaRS expression values.
2.3 Analysis of ASD implicated genes expression
The aim of the third part of this work was to study the role of MSNP1AS, a long
non coding RNA, in the regulation of ASD implicated genes. As MSNP1AS has
four MREs for miR-ASD, it could post-transcriptional regulate ASD implicated
genes by competing for binding of miR-ASD. A computational approach has been
adopted in order to first test the hypothesis as further experiments will be necessary
to confirm the mechanism. A non redundant list of ASD implicated genes has been
identified from published data available so far in the literature and their number of
MREs has been predicted. Brain transcriptome data from healthy adults and ASD
patients available in the GEO database have been analysed calculating the pairwise
correlation of expression values between all the possible gene pairs in two groups
(depending on the presence or the absence of MREs for the same microRNA), in
order to study the co-expression of the ASD implicated genes by comparison with
the remaining genes not implicated with ASD. Then the expression values of ASD
implicated genes has then been compared in order to study their relationship with
the increased ASD risk genotype.
Chapter 3
Materials and Method
3.1 Systematic analysis of the humanmRNA 5′ coding
sequences
3.1.1 Database construction
The 5'_ORF_Extender software parses and makes calculations on RefSeq
http://www.ncbi.nlm.nih.gov/RefSeq/ and EST database sequences. This is done
following the import of BLAT (BLAST-like alignment tool) genome alignment
data for human mRNAs and ESTs, in order to determine a list of genes with an
incompletely described mRNA 5′ coding sequence. The software has been devel-
oped using the FileMaker Pro 10 Advanced (FileMaker, Santa Clara, CA) database
management system for both Windows and Macintosh operating systems. It is
freely available as a stand-alone software (2.0 version) including the FileMaker
runtime and a step-by-step user tutorial at http://apollo11.isto.unibo.it/software/.
Due to the very large size and high complexity of the human genome and of
human EST database, together with the unavailability of a systematic assignment
of mRNA and EST sequences to a defined genomic locus (in the form of an official
gene symbol) in the UCSC data, an automated method of quality control of results
has introduced. This ex-ante control verifies if each investigated EST has been
assigned by UniGene http://www.ncbi.nlm.nih.gov/unigene system to the same lo-
cus as the mRNA sequence for which the EST is a possible candidate for 5′ end
extension. This has been made possible thanks to the availability of a UniGene
parser (the "UniGene Tabulator") able to produce a structured table including all
UniGene updated text information [Lenzi et al., 2006]. This table is imported into
the "UniGene_ID" table of the 5'_ORF_Extender software as a first step, allowing
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analysis to be limited to the mRNAs and corresponding ESTs that are mapped to
the same defined locus.
Then, the human RefSeq flat file (version October 18, 2011) was downloaded
from the UCSC (University of California, Santa Cruz) Genome Bioinformatics web
site (http://genome.ucsc.edu/ - "Tables" section). The text file was imported into
the "RefSeq_mRNA" table of the 5'_ORF_Extender software (following the soft-
ware user guide) in order to obtain a local RefSeq database with all the human
known reference mRNA sequences ("NM_" prefix, thus excluding RefSeq entries
not supported by experimental evidence, such as "XM_" models). It is possible
to only select and further analyse mRNA entries without an in-frame stop codon
upstream of the described initiation codon, which are thus candidates for a possible
extension at 5′ end: the presence of such a stop codon would indicate that the 5′
UTR sequence cannot be part of a longer continuous CDS. This also implies that
a database of all RefSeq mRNAs that are bona fide complete at the 5′ end of their
CDS is therefore generated.
The genome alignment data for human ESTs, assigned by UniGene to the same
locus of the mRNAs candidates for a possible extension at 5′ end, were then down-
loaded from the UCSC site (version October 19, 2011) and imported into the "EST_
Data" software table. Each human mRNA (without an in-frame stop codon upstream
of the described initiation codon) was then compared with all the human EST
assigned to the same locus by analysing the coordinates of the pre-computed genome
alignments for mRNAs and ESTs obtained by UCSC. Only those EST sequence
entries presenting additional nucleotides upstream of the known 5′ mRNA end and
therefore candidate to potentially extend the mRNA CDS at its 5′, were downloaded
and imported into the "EST_Seq" software table.
The whole analysis for H. sapiens, including UniGene data, mRNA and EST
data and sequences import and processing, required about 5 days for completion.
3.1.2 Computational analysis
The 5'_ORF_Extender analysis script performs the following steps (Fig. 3.1): ex-
traction of the EST sequence stretch upstream of the matched RefSeq mRNA first
base when BLAT alignment shows a 5′ extension of the EST compared with the
known RefSeq sequence (following removal of introns from both EST and mRNAs
genome-aligned sequences); a search in this EST stretch for the most upstream
existent ATG (corresponding to AUG in RNA) in-frame with the described one in
the RefSeq mRNA sequence entry; calculation of the new putative extended coding
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region by merging the EST extended stretch starting from the new ATG with the
previously known 5′ UTR of the RefSeq mRNA sequence; confirmation of the
coding potential of this new extended sequence by excluding the presence of any
in-frame stop codon within it.
It can also be estimated whether or not the determined extended CDS is complete,
by searching for any in-frame stop codon that might occur in the transcript upstream
of the newly determined start codon.
As a final result, the software provides a list of genes whose mRNA possesses
an extended 5′ CDS on the basis of EST comparison.
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Figure 3.1: Pipeline of the 5'_ORF_Extender software version 2.0 approach.
Sequence comparisons exploit BLAT-pre-computed UCSC genomic coordinates of
the RefSeq and EST sequences. Detailed explanation in the text. A. Identification
of RefSeq mRNA sequences without a known in-frame stop codon upstream of the
described initiation codon (and thus candidates for further extension of their CDS
at 5′). B. The parsed and embedded UniGene database allows the determination of
those EST sequences that cluster with each RefSeq mRNA sequence and that are
possible candidates for extending their 5′ coding region. C. Identification of EST
sequences with an upstream in-frame AUG codon and absence of any stop codon
between the previously and the newly determined AUG codons. D. Calculation of
the new extended open reading frame (new AUG codon indicated with an *)
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3.1.3 In vitro cloning and sequencing of the mRNA 5′ region
The sequence analysis predictions was confirmed of three example genes of the
5'_ORF_Extender results list. We utilised a reverse transcription-polymerase chain
reaction (RT-PCR) approach, based on the amplification of a stretch extended from
the new putatively defined 5′ UTR to at least as far as the known exon 2, in order
to prove that the amplified cDNA derived from mRNA. The human RNA sources
were: skeletal muscle, small intestine, ovary, brain and bone marrow total RNA
purchased from Clontech (Palo Alto, CA).
Standard reverse transcription conditions were: 2 µg of total RNA, Moloney
murine leukemia virus reverse-transcriptase (Promega, Madison, WI; used with the
companion buffer) 400 U, oligo dT-15 2.5 µM, random nonamers 2 µM, dNTPs 500
µM each. An RNA denaturation step was performed at 95◦C for 5 minutes before
the addition of primers and enzyme. RT reaction was performed in a final volume
of 50 µL for 60 minutes at 42◦C.
PCR experiments were performed in a 25 µL final volume, containing 2 µL of
cDNA, 1 U Taq polymerase (TaKaRa, Shiga, Japan) with companion reagents (0.2
mM each dNTPs, 2 mM MgCl2, 1× PCR buffer) and 0.2-0.3 µM of each primer.
An initial denaturation step of 2 minutes at 94◦C, followed by 40-48 cycles of 30
seconds at 94◦C, 30 seconds at the indicated annealing temperature (Ta, 61-64◦C),
30 seconds at 72◦C, and a final extension of 7 minutes at 72◦C. In one case (TDP2
cDNA), an additional step of reamplification (20 cycles) was conducted as above,
starting from 1 µL of sample obtained after the excision of the expected band from
agarose gel and its subsequent syringe-squeezing [Li and Ownby, 1993].
Primers pairs were designed with "Amplify3" software [Engels, 1993] following
standard criteria and are listed in Table 3.1.
All RT-PCR products obtained were gel analysed following a standard method
[Davis et al., 1994], purified using a GenElute kit (Sigma-Aldrich, St. Louis, MO),
and then subjected to automated sequence analysis of both DNA strands for each
fragment, using the same primers utilised in the respective PCR reactions. BigDye
chain-terminator method (Applied Biosystems, Carlsbad, CA) was used with an
automated Applied Biosystems ABI 3730 DNA automated sequencer.
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Gene (Gene full name) RefSeq Primer pairs sequence RT-PCR GenBank Product No. of new
Symbol mRNA (5′→ 3′) product size Human length amino acids
GenBank (F): Forward (tissue ESTa new/reference (% of
Accession No. (R): Reverse sources) reference)
length)
GNB2L1 Guanine nucleotide NM_006098 ggaattccatagttggtctc (F) 470 bp BU172346.1 395/317 78 (+25%)
binding protein cttgaatgtgcttgtttcagag (R) (Ovary, ES313379.1
(G protein), Brain) BP312588
beta polypeptide 2 BP244479
like 1
QARS Glutaminyl-tRNA NM_005051 ggatagacgaccttggagcg (F) 442 bp BI461626.1 793/775 18 (+2%)
synthetase gactccgcacatactcaagg (R) (Skeletal BI829834.1
Muscle, BI463065.1
Small BM560535
Intestine)
TDP2 Tyrosyl-DNA NM_016614 cgcagctgcaccagttttccgag (F) 383 bp BM554324.1 392/362 30 (+8%)
phosphodiesterase 2 ctcagagatggtttcaggtcg (R) (Brain, BG719977.1
Bone BP270589
Marrow) DA431403
Table 3.1: Experimentally confirmed extended cDNA 5′ coding region. aFour example EST sequences supporting an extended coding
sequence at 5′ region of the corresponding RefSeq mRNA, resulted from "5'_ORF_Extender" software analysis. GNB2L1, QARS and
TDP2 extensions were supported by a total of 5, 24 and 12 consistent ESTs, respectively.
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3.1.4 Sequence analysis
In order to test whether the newly determined CDS at 5′ was conserved in different
species, TBLASTN searches were performed using standard parameters, except the
filter for low complexity regions was unchecked. Alignment of the protein products
was made by ClustalW software (version 2.1 at:
http://www.ebi.ac.uk/Tools/msa/clustalw2/).
In order to identify novel domains which were not present in the described gene
products, the predicted extended amino acid sequences for the three example genes
were searched for in domain databases such as the Simple Modular Architecture
Research Tool (SMART, http://www.smart.embl-heidelberg.de/) and the Conserved
Domains Database (CDD, http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml).
3.2 Relationship between codon bias and expressed
RNA codons
3.2.1 Database construction
The "CODONOME" software parses and integrates RefSeq entries and expression
values data and then calculates how many codons are actually represented in the
transcriptome of a given tissue of an organism. The software has been devel-
oped using the FileMaker Pro 10 Advanced (FileMaker, Santa Clara, CA) database
management system for both Windows and Macintosh. The stand-alone software,
including the FileMaker runtime with a user guide included, is freely available to
basic users at http://apollo11.isto.unibo.it/software/.
The transcriptomes from the following species were investigated in order to
obtain data from higher- and lower-vertebrates as well as from invertebrates, unicel-
lular eukaryotes, and prokaryotes: H. sapiens, D. rerio, C. elegans, S. cerevisiae and
E. coli. First, the RefSeq mRNA flat files of the desired species were downloaded
from the NCBI ftp site (H. sapiens version May 7, 2010; D. rerio version June 16,
2010; C. elegans and S. cerevisiae versions January 18, 2011; E. coli version March
1, 2011). Each text file was edited (in order to create a tabulator key separated file
suitable for a File Maker table) and imported into the "RefSeq_Parser" table of the
"CODONOME" to obtain a specific local RefSeq database.
Following the execution of the "CODONOME" command, all but the "NM_"
type entries were deleted, thus excluding non-reviewed, predicted mRNA entries
(H. sapiens: 29,538 NM entries; D. rerio: 14,174 NM entries; C. elegans: 23,894
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NM entries; S. cerevisiae: 5,882 NM entries; E. coli: 4,319 NM entries). The same
script also counted each codon for each mRNA individually, then summed these
values to obtain the total number of each codon for the whole mRNAs pool (Fig.
3.2) and then calculated their per mil frequencies.
The expression data files for each species were downloaded from the GEO web
site. The Table 3.2 and the Table 3.3 list the investigated tissues and organisms
and the numbers of considered samples and experiment series. For human brain,
was performed a search with the word "brain" in GEO datasets, and arbitrarily
selected 24 samples from 7 different series in order to integrate representation from
different platforms (Affymetrix microarrays types), different authors, and different
investigated subjects, thus obtaining an integrated summarised gene expression pro-
file that best represents the general biological transcriptome map for that tissue
following both universal assignment of each probe to a specific locus via UniGene
data parsing [Lenzi et al., 2006] and intra- and inter-sample advanced normalisation
[Lenzi et al., 2011]. A similar process was performed in order to obtain gene ex-
pression profiles for other human tissues, including leukemic cells, as well as for
other species. For D. rerio and C. elegans, for which fewer studies are available, the
platform used in most experiments were chose: GPL1319 and GPL200, respectively.
Each expression data file was processed using TRAM software [Lenzi et al.,
2011]. "Set up" and "Importing the expression data files" software sections were
performed according to the software user guide. Then gene symbols with the
corresponding normalised expression values were exported in a text file for each
investigated species and imported it into the appropriate "Codonome" table of the
"CODONOME" database.
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Figure 3.2: Pipeline of the "CODONOME" software. For each RefSeq ("NM_"
type) entry considered, the occurrence of each codon was counted. Then the count
sum of each codon for the whole gene set was calculated (the per mil frequencies of
each codon sum in relation to the sum of all codons for the whole gene set gives the
codon bias). The codon count for each gene was then multiplied by the normalised
expression value of that gene. Finally, the total number of each codon for the whole
gene set was summed. The per mil frequencies of each codon sum in relation to
the sum of all codons for the whole gene set give the transcriptome codonome bias
(example simulation for a hypothetical gene set composed of three genes "A", "B"
and "C" assuming the existence of nine codons).
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Study ID Sample ID Sample Platform Microarray Spots Ref.
type
Pool "A" - healthy adults (n = 24)
A1...A8 GSM123271...78 Human post GPL96 U133A 22,283 [Lockstoe et al., 2007]
(n = 8) mortem
brain tissue
A9 GSM44690 Normal brain GPL96 U133A 22,283 [Ge et al., 2005]
(n = 1)
A10-A11 GSM12688, Normal brain GPL8300 U95 Version 2 12,625 [Yanai et al., 2005]
(n = 2) GSM12708
A12-A13 GSM12689, Normal brain GPL92 U95B 12,620 "
(n = 2) GSM12709
A14-A15 GSM12690, Normal brain GPL93 U95C 12,646 "
(n = 2) GSM12710
A16-A17 GSM12691, Normal brain GPL94 U95D 12,644 "
(n = 2) GSM12711
A18-A19 GSM12692, Normal brain GPL95 U95E 12,639 "
(n = 2) GSM12712
A20 GSM52556 Normal brain GPL96 U133A 22,283 [Detwiller et al., 2005;
(n = 1) Yoon et al., 2006]
A21-A22 GSM76949, Whole brain GPL570 U133 Plus 2.0 54,675 [Nguyen and
(n = 2) GSM76999 Disteche, 2006]
A23 GSM136140 Human control GPL96 U133A 22,283 [Padden et al., 2007]
(n = 1) brain tissue
A24 GSM112030 Brain GPL570 U133 Plus 2.0 54,675 [Auer et al., 2009]
(n = 1)
Pool "B" - healthy adult (n = 41)
B1...B14 GSM143572...85 Normal human GPL96 U133A 22,283 [Goh et al., 2007]
(n = 14) adult red
blood cells
B15...B28 GSM143671...76, Normal human GPL97 U133B 22,645 "
(n = 13) GSM143703, adult red
GSM143706...11 blood cells
B29...B35 GSM83897, Erythrocytes GPL201 HG-Focus 8,793 [Kabanova et al., 2009]
(n = 7) GSM85205...10
B36...B41 GSM440234...39 Reticulocytes GPL570 U133 Plus 2.0 54,675 [Noh et al., 2009]
(n = 6) from adult
periperal blood
Pool "C" - DS-AMKL children (n = 31)
C1...C3 GSM491372...4 BM GPL570 U133 Plus 2.0 54,675 [Klusmann et al., 2010]
(n = 3) Sorted leukemic
blasts
C4...C25 GSM94245, BM or PB GPL96 U133A 22,283 [Bourquin et al., 2006]
(n = 22) GSM94272...92
C26...C31 GSM417985...90 BM or PB GPL570 U133 Plus 2.0 54,675 [Klusmann et al., 2010]
(n = 6) Sorted leukemic
blasts
Table 3.2: Samples selected: Homo sapiens (pool "A", "B" and "C"). All Sample
IDs and Platform IDs are related to GEO database. Sample type: BM, bone marrow;
PB, peripheral blood. Microarray: U133A: Affymetrix Human Genome U133A
Array; U95 Version 2: Affymetrix Human Genome U95 Version 2 Array; U95B:
Affymetrix Human Genome U95B Array; U95C: Affymetrix Human Genome
U95C Array; U95D: Affymetrix Human Genome U95D Array; U95E: Affymetrix
Human Genome U95E Array; U133 Plus 2.0: Affymetrix Human Genome U133
Plus 2.0 Array; U133B: Affymetrix Human Genome U133B Array; HG-Focus:
Affymetrix Human HG-Focus Target Array.
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Study ID Sample ID Sample Platform Microarray Spots Ref.
type
Pool "D" - Wildtype adults (n=23)
D1 GSM74260 Brain GPL1319 [Zebrafish] 15,617 [Cameron et al., 2005]
(n=1) Affymetrix
Zebrafish
Genome
Affymetrix Array
D2...D4 GSM305891...93 " " " " [Lefebvre et al., 2009]
(n=3)
D5...D8 GSM280425...28 " " " " [Drew et al., 2008]
(n=4)
D9...D23 GSM337575...77, " " " " [Toyama et al., 2009]
(n=15) GSM337591...93, " " " "
GSM337604...06, " " " "
GSM337618...20, " " " "
GSM337631...33 " " " "
Pool "E" - Strain N2, wildtype young adults (n=19)
E1...E3 GSM214716, Whole GPL200 [Celegans] 22,625 [Asikainen et al., 2007]
(n=3) GSM214725, worm Affymetrix
GSM214727 C. elegans
Genome Array
E4...E7 GSM419959...62 " " " " [Krajacic et al., 2009]
(n=4) " " " "
E8...E12 GSM250116...20 " " " " [Falk et al., 2008]
(n=5) " " " " [Peng et al., 2008]
E13...E16 GSM40308...11 " " " " [Falk et al., 2008]
(n=4) " " " " [Peng et al., 2008]
E17...E19 GSM536251...53 " " " " [Falk et al., 2008]
(n=3) " " " " [Peng et al., 2008]
Pool "F" - Strain S288C, wildtype adults (n=19)
F1-F2 GSM248646-45 / GPL5092 Bauer Center 7,744 [Brown et al., 2008]
(n=2) for Genomics
Research
Saccharomyces
cerevisiae
70mer array,
Hartl Lab
F3 GSM34635 / GPL90 [YG_S98] 9,335 [Simons et al., 2006]
(n=1) Affymetrix
Yeast Genome
S98 Array
F4...F19 GSM67593, / " " " [Guan et al., 2006]
(n=16) GSM67610-19,
GSM67622-27,
GSM67596-99,
GSM67613-16,
GSM67630-33,
GSM67636-39,
GSM67602,
GSM67605-08,
Pool "G" - strain K-12, substr. MG1655, exponential growth, aerobic, wildtype (n=8)
G1...G3 GSM247608, / GPL199 [Ecoli_ASv2] 7,312 [Dong et al., 2008]
(n=3) GSM247612, Affymetrix
GSM247613 E. coli Antisense
Genome Array
G4-G5 GSM469137, / GPL3154 [E_coli_2] 10,208 [Moon and
(n=2) GSM469138 Affymetrix E. Gottesman 2009]
coli Genome 2.0
Array
G6...G8 GSM510322...24 / " " " [Holm et al., 2010]
(n=3)
Table 3.3: Samples selected: Danio rerio (pool "D"), Caenorhabditis elegans
(pool "E"), Saccharomyces cerevisiae (pool "F"), Escherichia coli (pool "G"). All
Samples IDs and Platforms IDs are related to GEO database. "/": not specified.
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3.2.2 Computational analysis
For each "NM_" mRNA-type entry considered the following step were performed:
was counted how many times each codon occurred; the count sum of each codon
for the whole gene set and the per mil frequency of each codon sum in relation to
the sum of all codon for the whole genome gene set (codon bias) were calculated;
the codon count for each gene was then multiplied by the normalised expression
value of that gene; the count of each codon for the whole gene set and the per
mil frequency of each codon sum in relation to the sum of all codon for the whole
genome gene set (codonome bias) were summed.
With these values, it is possible to search for relationships between codon usage
at genome and at transcriptome level.
To test the requirements for maintaining these relationships, casual changes in
the expression values of real genes were simulated in several tests. For the human
brain subset: the real genes’ expression values was twice permuted; another test
was performed importing non-normalised expression values exported from TRAM;
in the last test, the actual gene expression values were substituted with random
numbers from 1 to 104, reflecting the order of magnitude of the original dataset,
thereby executing a script.
For the human circulating blood erythrocytes subset, another test was performed
with random numbers (from 1 to 105, bigger than the actual maximum genes ex-
pression value) using the random numbers generator at www.randomizer.org, with
these parameters: 1 set of 26,589 unique and unsorted numbers per set, from 1 to
105. The created numbers were exported in a text file and imported in place of the
real expression values.
Lastly, a list of the twenty aaRS was created with the respective recognised
codons for H. sapiens, D. rerio, C. elegans, S. cerevisiae and E. coli. Codon and
codonome frequencies were then grouped by aaRS with the relative expression val-
ues (using the same expression data file as before).
3.2.3 Statistical analysis
Actual and simulated analyses results were exported in text files and submitted
to statistical analysis using statistical software for Mac OS X ("JMP software"
5.1.2, SAS Institute Inc., Cary, USA). The correlation between paired variables
was analysed through linear regression, setting the density ellipse at 0.50. In the
statistical analysis results "r" is the correlation coefficient and "p" represents the p
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value. The correlation was studied among the following parameters: a) codon bias,
b) codonome bias, c) codon bias grouped by aaRS, d) codonome bias grouped by
aaRS and e) the aaRS expression values ("a", "b", "c" and "d" are expressed as per
mil frequencies).
3.3 Analysis of ASD implicated genes expression
3.3.1 ASD implicated genes
A non redundant list of ASD implicated genes was compiled from available pub-
lished data [O’Roak et al., 2012; Neale et al., 2012; Sanders et al., 2012; Betancur,
2011; Anney et al., 2010; http://www.human-phenotype-ontology.org]. The soft-
ware TargetScan (http://www.targetscan.org/) was used in order to predict if these
ASD implicated genes have MREs for miR-ASD, in order to understand whether
MSNP1AS (that has four MREs for the same microRNA) can post-transcriptional
regulates ASD implicated genes by competing for binding of miR-ASD.
The expression data files for healty and ASD affected adults were downloaded
from the GEO web site, selecting only samples with known ASD implicated risk
genotype and only prefrontal or temporal cortex (Table 3.4), where expression
changes associated with ASD has been found to be more pronounced [Voineagu
et al., 2011]. An expression dataset from healthy fetal, child and adult prefrontal
cortex samples was downloaded (from the GEO web site as well) in order to under-
stand if there are changes during the normal brain development (Table 3.5).
Materials and Method 29
Study ID Sample ID Sample Platform Spots Ref.
type
Pool "A" - autism spectrum disorder (n = 27)
A1...A6 GSM706412...17 Human post mortem GPL6883 24,526 [Voineagu
(n = 6) prefrontal cortex et al., 2011]
A7...A15 GSM706444...56 " " " "
(n = 9)
A16...A19 GSM706444...47 Human post mortem " " "
(n = 4) temporal cortex
A20...A27 GSM706449...56 " " " "
(n = 8)
Pool "B" - healthy adult (n = 14)
B1...B4 GSM706429...32 Human post mortem GPL6883 24,526 [Voineagu
(n = 4) prefrontal cortex et al., 2011]
B5...B8 GSM706434 " " " "
(n = 4) GSM706436
GSM706439
GSM706441
B9...B11 GSM706458...60 Human post mortem " " "
(n = 3) temporal cortex
B12...B14 GSM706462 " " " "
(n = 3) GSM706464
GSM706467
Table 3.4: Samples selected with known ASD implicated risk genotype. All
Sample IDs and Platform IDs are related to GEO database. Microarray: Illumina
HumanRef-8 v3.0 Expression BeadChip.
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Study ID Sample ID Sample Platform Spots Ref.
type
Pool "C" - healthy fetal samples (n = 38)
C1...C38 GSM749899 Human post mortem GPL4611 49,152 [Colantuoni
(n = 38) GSM749900...36 dorsolateral et al., 2011]
prefrontal cortex
Pool "D" - healthy child samples 0-10 years (n = 33)
D1...D33 GSM749937...69 Human post mortem GPL4611 24,526 [Colantuoni
(n = 33) dorsolateral et al., 2011]
prefrontal cortex
Pool "E" - healthy adult samples (n = 198)
E1...E198 GSM749970...99 Human post mortem GPL4611 24,526 [Colantuoni
(n = 198) GSM750000...167 dorsolateral et al., 2011]
Prefrontal cortex
Table 3.5: Samples selected for human brain development. All Sample IDs and
Platform IDs are related to GEO database. Microarray: Illumina Human 49K Oligo
array (HEEBO-7 set).
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3.3.2 Statistical analysis
The following values were calculated developing appropriate scripts with Python (
http://www.python.org/) and compared using the software R [R Development Core
Team, 2008].
Expression values of each sample from ASD affected and healthy adults [Voineagu
et al., 2011] have been normalised using the median expression value of a list of ex-
pressed housekeeping genes [Eisenberg and Levanon, 2003].
Expression values from all the healty and ASD samples considered were divided
in two groups according to the following criteria: ASD implicated genes without
any MREs for miR-ASD; ASD implicated genes with at least one MRE for miR-
ASD. Then two groups of genes not implicated with ASD were created in order
to compare the two ASD implicated genes groups with the background: genes not
implicated with ASD were randomly picked in the same number of ASD implicated
genes respectively without and with MREs for 1000 permutations.
In each of these groups, the Pearson’s pairwise correlation coefficient of expres-
sion values between all the possible gene pairs was calculated. Then the median
value of the correlation coefficients was calculated for each group and for each of
the 1000 permutations. The calculated median value has been compared for ASD
implicated genes without any MREs for miR-ASD and with at least one MRE for
miR-ASD (separately) using as background the median values of the correlation
coefficient for each of the 1000 permutations. The p values have been calculated
as how many times the median value of the correlation coefficients calculated for
ASD implicated genes without MREs for miR-ASD (or with at least one MREs for
miR-ASD) is bigger than the median values calculated for the 1000 permutations of
genes not implicated with ASD. This analysis is useful to understand whether ASD
implicated genes are significantly more co-expressed than expected by chance in
the normal and in the pathological situation and during normal brain development.
Expression values for ASD implicated genes with and without MREs for miR-
ASD only from ASD affected adults were then compared dividing them depending
on the ASD implicated risk genpotype, in order to understand whether expression
values of ASD implicated genes with or without MREs for miR-ASD differ in the
genotype related with a higher risk and with a higher expression of MSNP1AS.
Chapter 4
Results
4.1 Systematic analysis of the humanmRNA 5′ coding
sequences
4.1.1 Database construction and computational analysis
The processing by 5'_ORF_Extender of 30,909 human RefSeq mRNA sequences
assigned by UniGene to a defined locus (out of a total of 31,903) revealed the
presence of an in-frame stop codon upstream of the known start codon in 20,775
cases. 10,134 sequences had a CDS which was putatively further extendable at
their 5′ end. 159,378 UCSC EST-to-genome alignments, for the ESTs candidate to
potentially extend the mRNA CDS at its 5′ in these 10,134 selected human mRNAs,
were then processed to identify positive final results. Following calculations exe-
cuted by the software, it was possible to obtain candidate extended coding regions
at 5′ end from 2,505 ESTs (Table 4.1).
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Summary of analysis
Human loci analysed 18,665
Human Reference mRNAs (RefSeq) analysed 31,903
Human RefSeq mRNA sequences assigned by UniGene to a defined locus 30,909
mRNAs with CDS not extendable at 5´ end (in-frame stop codon located 20,775
upstream of the known start codon)
mRNAs with CDS possibly further extendable at 5′ end 10,134
ESTs assigned to the same locus of the 10,134 mRNAs possibly further 7,166,113
extendable at 5′ end
EST-to-genome alignments for the EST candidates to potentially extend 159,378
the mRNA CDS at their 5′ end
Final set of results
ESTs with putative CDS extension 2,505
mRNAs with putative extension of their known CDS at 5′ end 615
Loci with putative extension of their known CDS at 5′ end 477
Mean number of ESTs with extended sequence per mRNA 4.1
Mean length of extended 5′ CDS 178.5
Standard Deviation of the extended 5′ CDS length 134.8
Minimum length of extension 3
Maximum length of extension 1,014
mRNAs with CDS extension supported by more than one EST 298
mRNAs with CDS extension supported by more than one EST not 270
derived from the same library
Loci with CDS extension supported by more than one EST 232
Loci with CDS extension supported by more than one EST not 213
derived from the same library
Table 4.1: Summary of computational analysis. CDS, coding sequence. Length is
given in nucleotides.
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4.1.2 Summarisation of results
The final set of 2,505 ESTs corresponded to 477 distinct human loci (2.6% of all
studied genes with a RefSeq sequence) (Table 4.1). The mean number of EST
sequences that allowed the extension of one mRNA sequence was 4.1, with 298
different mRNAs extended by at least two distinct EST sequences. In particular,
the ESTs extending 270 out of these 298 mRNAs were not derived from the same
library. The mean size of the additional open reading frames (ORF) stretch was
178.5 bases, with a standard deviation of 134.8 bases (range: 3-1,014 bases) (4.1).
An example of the "Result" table of the 5'_ORF_Extender software is shown if Fig.
4.1.
For 224 genes (46.96%) it can be estimated that the determined extended CDS
is complete, due to the presence of an in-frame stop codon upstream of the newly
determined start codon.
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Figure 4.1: Example of the 5'_ORF_Extender software’s "Results" table.
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4.1.3 In vitro cloning and sequencing of the mRNA 5′ region
The predicted additional coding region was cloned for each of the three example
genes: GNB2L1, QARS and TDP2 (Table 3.1). The expected size bands corre-
sponding to the amplified GNB2L1, QARS and TDP2 5′ regions are shown in Fig.
4.2 and the electropherogram obtained after QARS 5′ region sequencing is shown
in Fig. 4.3.
The nucleotide sequences of the extended coding regions determined exactly
between the 3′ end of the primer pairs for GNB2L1, QARS and TDP2 cDNAs have
been deposited in the GenBank database under accession nos. JN104586, JN104585
and JN104587, respectively.
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Figure 4.2: Expected band size corresponding to the amplified 5′ regions in a 1.5%
agarose gel. Lane M: Marker GeneRuler Ladder. Lane 1: GNB2L1, 470 bp, brain.
Lane 2: QARS, 442 bp, small intestine. Lane 3: TDP2, 383 bp, brain.
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Figure 4.3: Electropherogram of QARS 5′ region sequencing. The green and
the red rectangles underline the previously and newly determined AUG codons,
respectively. Asterisk: in-frame stop codon upstream of the newly determined start
codon.
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4.1.4 Sequence analysis
The extended coding sequences for GNB2L1, QARS and TDP2 were analysed using
the TBLASTN program in order to compare them with known nucleotide sequences
deposited in the NCBI databases. This confirmed that no human matching sequence
had been previously deposited in the "mRNA" (molecular type) division of GenBank,
except two sequences (#AK302867 and #AK298699) relating to QARS and TDP2,
respectively. Although these sequences are not present in the GenBank EST division,
they were generated in the context of the NEDO large-scale cDNA sequencing
project [Yudate et al., 2001] and the relative entries were not tagged with the cor-
responding gene symbol as well as their predicted proteins (classified as "unnamed
protein product"). They were not used by the genome browsers NCBI Map Viewer
[Sayers et al., 2011] and University of California at Santa Cruz (UCSC) Genome
Browser [Sanborn et al., 2011] to build mRNA models with the extended CDS.
mRNA models including the extended CDS reported here for QARS (Ensembl Entry
ENST00000420147) and TDP2 (Ensembl Entry ENST00000545995), but not for
GNB2L1, were available at the European Bioinformatics Institute (EBI) Ensembl
genome browser [Flicek et al., 2011]. These CDSs were not however included in the
entries containing coding sequences (Ensembl CCDS) available for the two genes,
respectively, and the mRNA models were mainly based on mRNA sequences. These
include the aforementioned "mRNA" sequences relating to QARS and TDP2, with
limited support from available ESTs (2 ESTs out of the 24 identified by 5'_ORF_Ex-
tender in the case of QARS and 2 out of the 12 in the case of TDP2). In addition,
as stated in the Ensembl genome annotation documentation, EST alignments are
displayed on the website but are not usually used as supporting evidence in the
gene-building process. The nucleotide and amino acid analysis data are summarised
in the Table 3.1.
Sequence comparison also showed the presence of high conservation of the
extended stretch with predicted proteins in non human primates, a finding consistent
with the coding nature of these regions (Fig. 4.4).
The amino acid sequences predicted at the amino terminus of these three genes
did not show new known functional domains through database searches.
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Figure 4.4: ClustalW alignment of GNB21L (A), QARS (B) and TDP2 (C) protein
sequences from different species. Human sequences are derived from the original
cDNA sequencing data presented here. The methionine corresponding to the
previously determined start codon in the human mRNA reference sequence is
underlined, followed by the first 20 amino acids of the reference protein sequence.
HUMAN: Homo sapiens, PANTR: Pan troglodytes, PONAB: Pongo abelii, HILLE:
Nomascus leucogenys, MACMU: Macaca mulatta, CALJA: Callithrix jacchus.
Asterisk: residue conserved in all sequences; colon: conservative substitution; dot:
less conservative substitution.
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4.2 Relationship between codon bias and expressed
RNA codons
4.2.1 Database construction and computational analysis
Following importation of the normalised expression data, available expression val-
ues were found for: 27,850 out of 29,538 NM RefSeq entries for human brain
tissue; 26,589 out of 29,538 NM entries for human circulating blood erythrocyte;
27,506 out of 29,538 NM entries for human DS AMKL cells; 6,642 out of 14,174
NM entries in D. rerio; 19,281 out of 23,894 NM for C. elegans; 4,673 out of 5,882
NM for S. cerevisiae; 2,426 out of 4,319 NM for E. coli. A summary of the range
in the expression data and of the main genes with the highest and lowest expression
values for the considered datasets is given in Table 4.2 for H. sapiens and Table 4.3
for the other investigated species available.
The frequency of each codon at genome level corresponds to the codon bias
values already known for each genome [Nakamura Y, Codon Usage Database
http://www.kazusa.or.jp/codon/]. In addition, codon sums at transcriptome level
(codonome value), accounting for the abundance of each mRNA bearing that codon,
has been calculated as per mil frequencies of each codon, obtaining the codonome
bias (see Table 4.4 and Table 4.5 for H. sapiens, Table 4.6 for the other investigated
species and Table 4.7 for human simulations).
Per mil frequencies for each codon (at genome level and at transcriptome level)
were also grouped by the corresponding aaRS and then their expression values were
loaded from the same normalised files as before. With the exception of H. sapiens,
we could not find expression values for some aaRS for any of the investigated
species (see Table 4.8 for H. sapiens and Table 4.9 for the other investigated species).
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Homo sapiens
Brain Erythrocytes DS-AMKL cells
Gene symbol Value Gene symbol Value Gene symbol Value
UBC 3088.81 HBA2 47816.17 RPS18 6592.43
TUBA1B 3044.12 SLC25A39 43176.51 RPL41 6588.66
TUBA1C 2634.12 HBA1 36616.34 EEF1A1 6583.97
UBB 2591.82 HBB 31649.48 RPS10 6233.13
CALM2 2577.65 UBB 25239.87 RPS3A 6175.32
RPL41 2549.75 RPL21 20966.99 RPL23A 6078.20
GAPDH 2316.03 HBM 18959.67 RPS23 5836.76
RPL23A 2170.38 STRADB 18836.62 TPT1 5814.83
SPARCL1 2075.33 HBG2 15431.72 RPS3 5769.17
CFL1 2019.56 GYPC 12556.57 RPLP0 5579.53
C7orf72 7.07 RBL1 2.19 AWAT1 1.15
FBXO47 7.06 C14orf105 2.14 DSG4 1.14
FABP12 7.04 AHR 2.12 UBL4B 1.14
ACER2 6.73 ZNF165 1.96 MAS1L 1.14
CXorf51 6.23 C17orf75 1.92 KCTD21 1.13
PTPRQ 5.82 TMEM232 1.63 TTC16 1.11
SLC36A2 5.75 IFT74 1.59 TSSK3 1.09
RSPH4A 5.33 SLC16A4 1.29 DEFB118 1.07
TAS2R20 4.41 ZNF674 1.28 SERINC2 1.04
C5orf52 4.36 DMXL1 1.13 CCDC135 1.04
Table 4.2: The ten human genes with the highest and the lowest expression values
in the studied datasets. The units of expression are given, following intra- and inter-
sample normalisation by the TRAM software, as percentage of the mean value.
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Danio Caenorhabditis Saccharomyces Escherichia
rerio elegans cerevisiae coli
Brain Whole worm
Gene Value Gene Value Gene Value Gene Value
symbol symbol symbol symbol
mrps7 7051.00 col-93 1501.63 CCW12 561.08 rplA 989.00
epd 3800.07 rpl-3 1394.01 RPL42B 488.58 rplE 358.99
rpl12 2004.90 rpl-2 1388.10 SSA1 471.06 rpsN 860.42
rpl35a 1902.82 col-92 1383.15 CWP2 457.85 rplV 844.00
rps25 1815.57 rps-25 1378.99 TDH3 456.72 rplP 841.89
rpl6 1776.76 asp-1 1363.07 ENO1 448.49 cspC 835.24
uba52 1708.42 rps-4 1353.35 HOR7 445.87 rplC 803.48
ef1a 1662.62 rps-1 1350.21 RPS21B 431.01 rpsA 784.36
rps14 1589.81 eft-3 1333.51 CDC19 428.76 rplD 766.37
rpl35 1581.87 act-2 1331.33 HHF2 423.98 atpF 766.21
zgc:136367 1.66 srg-45 35.20 UAF30 33.23 ydiS 19.94
crygm2c 1.65 srx-116 35.00 MND1 32.22 mfd 15.58
ahr1a 1.61 srsx-22 34.92 OSW1 32.21 ydiM 15.43
otx5 1.60 K05C4.3 34.90 MEI4 31.89 yegD 6.30
pth1rb 1.54 C16C4.1 34.83 YPT53 31.18 lolE 5.44
lhx3 1.51 C33E10.6 34.55 SPO74 30.85 yeiT 4.04
nr5a5 1.51 fbxa-159 34.51 ERR2 29.28 mobB 3.90
mpll 1.49 srh-88 34.03 RPL34B 28.73 yihU 3.59
hoxa9b 1.44 sre-20 33.75 YRF1-7 27.51 fadL 2.98
insb 1.44 srv-30 33.15 RPL40B 27.09 HHF2 0.24
Table 4.3: The ten genes with the highest and the lowest expression values in the
studied datasets. The units of expression are given, following intra- and inter-
sample normalisation by the TRAM software, as percentage of the mean value.
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Homo sapiens
Brain Erythrocytes DS-AMKL cells
Codon Codon Codonome Codon Codonome Codon Codonome
bias bias bias bias bias bias
AAA 25.88 24.46 25.83 22.04 25.84 27.86
AAC 18.90 19.18 18.94 19.37 18.93 18.89
AAG 32.30 34.17 32.41 35.26 32.32 37.13
AAT 17.58 16.52 17.52 14.76 17.56 17.74
ACA 15.41 14.58 15.36 13.51 15.42 14.95
ACC 18.40 19.06 18.42 21.55 18.44 18.12
ACG 5.96 6.19 5.98 5.92 5.97 5.41
ACT 13.53 12.97 13.49 12.77 13.52 14.10
AGA 12.23 11.30 12.14 10.54 12.18 12.40
AGC 19.72 19.73 19.74 20.38 19.75 17.55
AGG 11.64 11.34 11.56 11.51 11.61 10.93
AGT 12.87 12.19 12.85 11.36 12.83 12.39
ATA 7.60 6.72 7.51 5.59 7.58 6.89
ATC 20.06 21.16 20.13 22.21 20.13 20.65
ATG 21.45 22.00 21.49 22.13 21.48 22.78
ATT 16.20 15.67 16.18 13.94 16.22 17.41
CAA 12.84 11.63 12.74 10.99 12.80 12.06
CAC 14.80 14.79 14.77 16.03 14.81 13.74
CAG 34.76 35.29 34.83 35.46 34.76 34.31
CAT 11.12 10.40 11.05 9.87 11.10 10.72
CCA 17.67 17.03 17.69 16.64 17.63 17.52
CCC 19.81 20.50 19.84 22.17 19.81 18.67
CCG 6.97 7.32 6.97 7.48 6.96 6.34
CCT 18.17 17.86 18.19 18.20 18.13 18.41
CGA 6.28 6.34 6.33 6.21 6.28 6.81
CGC 10.10 10.98 10.13 11.46 10.12 10.33
CGG 11.47 12.14 11.56 13.05 11.49 11.24
CGT 4.54 4.82 4.56 4.81 4.53 5.67
CTA 7.09 6.57 7.07 6.43 7.08 6.82
CTC 18.51 18.68 18.48 19.81 18.54 17.10
CTG 38.38 39.51 38.39 43.61 38.43 36.10
CTT 13.33 12.57 13.28 11.88 13.30 13.64
Table 4.4: The per mil frequencies of codons (codon bias) and the per mil
frequencies of the codon counts multiplied by the respective expression value
(codonome bias) in the human studied datasets. First part.
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Homo sapiens
Brain Erythrocytes DS-AMKL cells
Codon Codon Codonome Codon Codonome Codon Codonome
bias bias bias bias bias bias
GAA 31.28 30.18 31.26 26.45 31.21 32.33
GAC 25.23 26.43 25.34 26.67 25.27 24.65
GAG 40.42 42.76 40.54 41.98 40.41 40.03
GAT 22.88 22.85 22.97 20.38 22.90 24.79
GCA 16.32 16.14 16.34 15.02 16.30 16.89
GCC 27.43 28.96 27.48 31.43 27.48 27.10
GCG 7.13 7.63 7.12 8.25 7.12 6.81
GCT 18.45 18.91 18.48 18.39 18.43 20.92
GGA 16.70 16.16 16.68 15.15 16.70 17.12
GGC 21.80 22.88 21.87 25.27 21.83 21.68
GGG 15.96 16.27 15.96 16.46 15.97 14.96
GGT 10.73 10.91 10.76 11.13 10.73 12.51
GTA 7.30 6.88 7.30 6.13 7.29 7.69
GTC 13.99 14.29 14.01 14.67 14.03 13.88
GTG 27.22 28.26 27.32 31.29 27.30 27.21
GTT 11.23 10.86 11.25 9.83 11.23 12.49
TAA 0.66 0.74 0.66 0.96 0.66 1.00
TAC 14.58 15.00 14.61 15.29 14.60 14.16
TAG 0.49 0.52 0.49 0.52 0.49 0.53
TAT 12.12 11.61 12.08 10.92 12.11 12.44
TCA 12.78 11.83 12.70 11.27 12.73 11.93
TCC 17.41 17.63 17.39 18.29 17.41 16.43
TCG 4.45 4.65 4.46 4.66 4.46 4.04
TCT 15.38 14.74 15.36 14.18 15.35 15.59
TGA 1.10 1.17 1.10 1.48 1.10 1.19
TGC 11.78 11.57 11.70 11.59 11.79 10.11
TGG 12.09 11.78 12.05 12.39 12.09 11.20
TGT 10.38 9.53 10.26 9.23 10.34 9.38
TTA 7.96 7.05 7.94 5.74 7.94 7.56
TTC 19.09 19.39 19.07 20.83 19.12 18.36
TTG 12.89 12.38 12.88 11.55 12.88 13.06
TTT 17.20 16.35 17.16 15.66 17.19 17.25
Table 4.5: The per mil frequencies of codons (codon bias) and the per mil
frequencies of the codon counts multiplied by the respective expression value
(codonome bias) in the human studied datasets. Second part.
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D. rerio C. elegans S. cerevisiae E. coli
Codon Codon Codonome Codon Codonome Codon Codonome Codon Codonome
bias bias bias bias bias bias bias bias
AAA 29.31 28.93 37.00 33.64 42.56 39.61 35.04 39.83
AAC 23.69 25.12 18.33 19.70 24.67 25.19 21.87 23.73
AAG 31.60 39.32 25.82 30.59 31.22 33.21 10.26 11.96
AAT 15.63 14.22 30.11 27.63 36.41 33.35 17.53 15.07
ACA 16.50 14.68 20.40 18.37 17.69 16.51 7.13 5.99
ACC 16.20 18.02 10.34 12.45 12.35 13.54 23.55 24.59
ACG 7.32 6.66 8.84 7.99 8.05 7.47 14.29 12.59
ACT 14.05 13.15 19.34 19.22 20.11 21.14 9.03 10.23
AGA 14.79 13.55 15.32 14.99 21.45 22.43 2.03 1.77
AGC 18.50 17.29 8.28 7.94 9.79 9.08 16.09 15.32
AGG 10.46 10.83 3.73 3.09 9.53 8.67 1.23 0.96
AGT 13.20 11.24 12.25 10.85 14.38 13.28 8.56 7.07
ATA 6.81 5.17 9.20 7.04 17.81 15.55 4.54 3.42
ATC 23.29 26.72 18.73 20.62 16.90 17.98 25.00 27.98
ATG 15.56 15.52 32.17 29.52 30.40 30.53 29.82 27.78
ATT 24.92 26.47 26.14 25.33 20.65 20.57 27.23 27.55
CAA 12.31 10.54 27.72 28.64 27.25 27.55 15.14 13.50
CAC 14.90 14.10 9.00 9.65 7.50 7.88 9.78 10.61
CAG 34.91 34.52 14.47 14.67 12.36 11.53 29.17 29.46
CAT 11.27 10.20 14.08 13.36 13.52 12.96 12.82 11.35
CCA 15.89 14.61 26.74 30.36 17.77 19.17 8.39 7.75
CCC 12.89 13.59 4.32 3.81 6.80 6.44 5.38 4.38
CCG 8.17 7.11 9.61 8.83 5.18 4.72 23.60 24.20
CCT 16.92 16.34 8.97 8.17 13.31 13.13 6.82 6.34
CGA 7.08 6.29 12.08 10.95 2.88 2.39 3.51 2.91
CGC 9.85 11.07 5.02 6.37 2.49 2.32 22.27 22.01
CGG 6.87 6.27 4.58 3.95 1.70 1.47 5.50 4.44
CGT 7.15 9.26 11.31 13.49 6.26 6.67 20.83 24.58
CTA 6.17 5.20 7.75 6.43 13.44 12.85 3.96 3.16
CTC 17.01 16.97 14.61 16.51 5.23 4.74 11.15 10.14
CTG 37.44 37.67 11.95 10.79 10.66 9.97 53.11 55.63
CTT 12.64 11.69 21.39 22.30 11.90 11.04 10.81 9.46
GAA 25.12 24.12 41.64 40.65 46.79 46.98 39.50 42.83
GAC 28.21 29.38 17.22 18.42 20.36 21.05 19.46 21.89
GAG 44.54 47.92 24.68 27.25 19.81 18.69 17.99 18.41
GAT 25.15 24.97 36.67 36.68 38.74 37.36 32.25 30.78
GCA 16.81 16.26 20.38 19.04 16.24 15.72 19.98 20.72
GCC 19.82 23.22 12.57 15.75 12.47 14.16 25.74 23.79
GCG 8.52 7.86 8.20 7.55 6.21 5.94 34.01 33.19
GCT 21.25 23.49 22.90 25.88 20.71 24.31 15.12 18.20
GGA 21.81 22.65 32.11 37.70 10.90 10.09 7.83 6.61
GGC 17.58 19.59 6.55 6.14 9.72 9.68 30.31 31.33
GGG 9.97 9.40 4.31 3.71 6.09 5.81 11.11 9.44
GGT 13.90 16.06 11.03 10.92 23.48 27.76 24.82 28.10
GTA 6.37 5.75 9.90 8.79 11.83 10.95 10.81 12.03
GTC 14.63 15.60 13.63 15.92 11.39 13.08 15.10 14.28
GTG 27.63 27.82 14.37 13.34 10.87 10.62 26.50 25.35
GTT 13.68 13.18 24.55 25.29 21.98 23.86 17.97 20.91
TAA 1.22 1.69 1.04 1.21 0.94 1.07 1.98 2.30
TAC 16.39 17.17 13.71 14.53 14.33 15.28 12.20 13.04
TAG 0.53 0.70 0.37 0.38 0.43 0.43 0.24 0.20
TAT 11.97 11.38 17.43 15.64 18.60 17.67 15.82 14.21
TCA 13.17 10.92 20.88 19.09 18.64 17.29 7.05 5.89
TCC 15.19 15.12 10.50 11.40 14.10 15.05 8.70 9.42
TCG 5.49 4.82 12.22 11.86 8.57 8.04 8.98 7.73
TCT 16.84 15.51 16.97 16.97 23.52 24.59 8.39 9.55
TGA 2.17 2.18 0.69 0.59 0.55 0.55 1.01 0.92
TGC 11.02 10.15 8.81 8.84 4.53 4.21 6.34 5.77
TGG 11.52 10.86 10.87 10.42 10.28 10.36 15.28 13.50
TGT 11.06 8.85 10.89 9.64 7.78 7.80 4.90 4.31
TTA 6.25 4.67 9.57 7.72 26.55 25.46 13.56 10.81
TTC 19.99 20.69 23.53 24.43 18.05 19.15 16.39 18.27
TTG 11.81 10.58 19.88 18.60 27.34 29.41 13.37 11.56
TTT 17.07 15.11 22.32 18.39 25.95 24.68 21.85 18.88
Table 4.6: The per mil frequencies of codons (codon bias) and the per mil
frequencies of codon counts multiplied by the relative expression value (codonome
bias) in: Danio rerio, Caenorhabditis elegans, Saccharomyces cerevisiae and
Escherichia coli.
Results 47
Homo sapiens
Brain Erythrocytes
Permutation Permutation Raw Data Random Numbers Random Numbers
1 2 (from 1 to 104) (from 1 to 105)
Codon Codon Codonome Codonome Codonome Codonome Codon Codonome
bias bias bias bias bias bias bias
AAA 25.88 26.24 25.78 24.90 25.88 25.83 22.88
AAC 18.90 18.83 18.89 19.35 18.94 18.94 15.45
AAG 32.30 32.65 32.19 33.40 32.32 32.41 27.83
AAT 17.58 17.53 17.47 16.99 17.51 17.52 15.12
ACA 15.41 15.53 15.31 15.01 15.42 15.36 14.73
ACC 18.40 18.39 18.30 18.79 18.47 18.42 15.68
ACG 5.96 5.94 5.97 6.16 5.98 5.98 6.76
ACT 13.53 13.64 13.40 13.06 13.53 13.49 13.90
AGA 12.23 12.21 12.26 11.48 12.16 12.14 13.40
AGC 19.72 19.66 19.94 19.84 19.81 19.74 19.47
AGG 11.64 11.55 11.82 11.26 11.59 11.56 8.74
AGT 12.87 12.93 12.81 12.48 12.83 12.85 15.20
ATA 7.60 7.71 7.54 6.97 7.56 7.51 7.47
ATC 20.06 20.03 19.97 20.97 20.01 20.13 15.34
ATG 21.45 16.39 16.12 15.86 16.15 21.49 19.38
ATT 16.20 21.57 21.41 21.88 21.42 16.18 10.71
CAA 12.84 12.87 12.85 12.03 12.78 12.74 8.12
CAC 14.80 14.74 14.75 14.74 14.84 14.77 16.71
CAG 34.76 34.34 34.95 35.46 34.78 34.83 38.22
CAT 11.12 11.16 11.13 10.55 11.10 11.05 9.06
CCA 17.67 17.86 17.67 17.42 17.70 17.69 23.64
CCC 19.81 19.68 19.99 20.05 19.81 19.84 27.68
CCG 6.97 6.92 7.07 6.89 6.98 6.97 8.57
CCT 18.17 18.31 18.24 18.03 18.18 18.19 24.51
CGA 6.28 6.22 6.36 6.45 6.30 6.33 7.67
CGC 10.10 9.85 10.10 10.48 10.14 10.13 11.18
CGG 11.47 11.15 11.52 12.02 11.50 11.56 16.70
CGT 4.54 4.48 4.53 4.70 4.56 4.56 4.52
CTA 7.09 7.14 7.10 6.80 7.07 7.07 6.33
CTC 18.51 18.42 18.58 18.62 18.51 18.48 22.69
CTG 38.38 37.84 38.52 39.13 38.43 38.39 38.97
CTT 13.33 13.44 13.29 12.81 13.30 13.28 12.20
GAA 31.28 31.40 31.35 30.61 31.24 31.26 28.01
GAC 25.23 25.07 25.31 26.13 25.24 25.34 25.77
GAG 40.42 40.26 40.69 42.02 40.41 40.54 39.27
GAT 22.88 23.00 22.73 23.16 22.89 22.97 30.11
GCA 16.32 16.46 16.27 16.23 16.31 16.34 15.45
GCC 27.43 27.33 27.51 28.20 27.51 27.48 30.64
GCG 7.13 7.10 7.15 7.11 7.17 7.12 8.71
GCT 18.45 18.46 18.39 18.65 18.46 18.48 18.71
GGA 16.70 16.61 16.79 16.38 16.67 16.68 12.79
GGC 21.80 21.62 21.99 22.33 21.91 21.87 20.63
GGG 15.96 15.96 16.00 16.09 15.97 15.96 20.74
GGT 10.73 10.75 10.75 10.84 10.78 10.76 10.78
GTA 7.30 7.37 7.23 7.07 7.28 7.30 5.82
GTC 13.99 14.04 14.01 14.29 14.06 14.01 12.99
GTG 27.22 27.21 27.17 28.10 27.29 27.32 28.64
GTT 11.23 11.39 11.08 10.97 11.20 11.25 10.47
TAA 0.66 0.72 0.68 0.61 0.66 0.66 0.38
TAC 14.58 14.44 14.52 15.01 14.61 14.61 18.41
TAG 0.49 0.51 0.50 0.48 0.50 0.49 0.37
TAT 12.12 12.05 12.13 11.82 12.08 12.08 7.45
TCA 12.78 12.92 12.61 12.13 12.69 12.70 11.52
TCC 17.41 17.59 17.39 17.54 17.40 17.39 19.89
TCG 4.45 4.43 4.52 4.52 4.47 4.46 4.74
TCT 15.38 15.52 15.32 14.99 15.35 15.36 17.44
TGA 1.10 1.16 1.12 1.06 1.10 1.10 0.77
TGC 11.78 11.57 11.68 11.50 11.76 11.70 8.84
TGG 12.09 12.02 12.13 11.86 12.05 12.05 8.90
TGT 10.38 10.32 10.23 9.68 10.36 10.26 5.68
TTA 7.96 8.01 7.94 7.37 7.91 7.94 8.60
TTC 19.09 19.22 18.95 19.38 19.12 19.07 21.06
TTG 12.89 12.95 12.87 12.56 12.86 12.88 11.67
TTT 17.20 17.30 17.16 16.69 17.12 17.16 15.88
Table 4.7: The per mil frequencies of codons (codon bias) and the per mil
frequencies of expressed codons (codonome bias). In these analyses the real genes
expression values has been substituted with: permuted values (two examples), raw
data (values non-normalised by TRAM), random numbers from 1 to 104 and random
numbers from 1 to 105.
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Homo sapiens
Brain Erythrocytes DS-AMKL cells
Gene Codon Codonome Expression Codon Codonome Expression Codon Codonome Expression
symbol bias bias value bias bias value bias bias value
AARS 69.33 71.62 340.77 69.43 73.21 111.55 69.25 71.43 182.57
CARS 22.19 21.13 171.68 22.01 20.82 65.49 22.24 19.61 112.81
DARS 48.08 49.27 90.51 48.29 47.04 27.13 48.00 49.33 265.46
EPRS 134.34 135.65 97.28 134.55 132.93 45.11 134.03 133.57 139.06
FARSA 36.30 35.73 116.50 36.24 36.50 45.93 36.31 35.49 88.23
FARSB 36.30 35.73 83.59 36.24 36.50 96.01 36.31 35.49 72.70
GARS 65.26 66.21 240.98 65.33 68.30 78.81 65.04 65.97 350.40
HARS 25.92 25.20 192.71 25.83 25.88 8.31 25.97 24.50 116.31
IARS 49.10 49.88 246.07 49.10 49.92 21.82 49.08 50.17 357.47
KARS 58.19 58.65 202.52 58.24 57.26 227.30 58.16 64.99 629.51
LARS 98.21 96.84 141.49 98.08 98.94 51.21 98.19 94.30 169.68
MARS 16.17 15.64 122.54 16.14 13.92 48.41 16.22 17.36 97.31
NARS 36.43 35.66 425.68 36.43 34.20 20.20 36.47 36.56 291.97
QARS 47.63 46.94 162.10 47.58 46.40 23.15 47.59 46.46 863.36
RARS 56.30 56.97 78.05 56.32 57.59 11.25 56.38 57.85 87.05
SARS 82.57 80.85 255.34 82.48 79.96 60.12 82.71 78.21 187.42
TARS 53.20 52.67 76.46 53.15 53.56 79.01 53.30 52.36 144.87
VARS 59.71 60.30 75.19 59.81 61.83 72.68 59.72 61.00 64.98
WARS 12.08 11.75 137.52 12.03 12.40 29.93 12.16 11.23 135.00
YARS 26.70 26.58 172.73 26.68 26.34 87.21 26.65 26.67 267.99
Table 4.8: The per mil frequencies of codons grouped by aminoacyl-tRNA synthetase (codon bias by aaRS), the per mil frequencies
of the expressed codon grouped by aminoacyl-tRNA synthetase (codonome bias by aaRS), and the aminoacyl-tRNA synthetases
expression values in human studied datasets.
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Species Gene Codon Codonome Expression Species Gene Codon Codonome Expression
symbol bias bias value symbol bias bias value
D. rerio aars 66.40 70.84 139.36 S. cerevisiae ALA1 55.62 60.13 162.49
cars 22.07 19.00 23.19 CDC60 95.12 93.46 143.93
eprs 123.52 123.69 / DED81 61.08 58.54 192.22
farsa 37.06 35.80 / DPS1 59.10 58.40 260.83
farsb 37.06 35.80 43.88 FRS1 44.00 43.83 260.76
hars 26.16 24.31 103.73 FRS2 44.00 43.83 156.46
iars 55.03 58.36 12.94 GLN4 39.62 39.08 118.51
kars 60.91 68.25 115.32 GRS1 50.19 53.35 180.08
lars 91.33 86.78 / GUS1 66.61 65.67 219.64
mars 15.56 15.52 9.68 HTS1 21.02 20.84 162.48
qars 47.22 45.05 13.39 ILS1 55.36 54.10 154.64
rars 56.20 57.27 16.17 KRS1 73.79 72.82 218.47
sars 82.39 74.91 / MES1 30.40 30.53 164.98
si:dkey-274m14.2 39.33 39.34 / SES1 88.99 87.33 188.41
si:dkey-276i5.1 63.27 67.70 105.94 THS1 58.21 58.65 224.02
tars 54.08 52.51 43.84 TYS1 32.94 32.94 147.53
vars 62.30 62.35 10.03 VAS1 56.08 58.51 168.58
wars 11.52 10.86 27.10 WRS1 10.28 10.36 155.73
wu:fc17a11 53.36 54.35 / YDR341C 44.31 43.93 /
yars 28.37 28.56 23.35 YHR020W 43.06 43.47 /
YNL247W 12.31 12.00 /
C. elegans ars-2 64.05 68.23 149.15 E. coli alaS 94.84 95.90 364.21
crs-1 19.70 18.48 123.51 argS 55.38 56.67 174.99
drs-1 53.89 55.10 249.92 asnS 39.40 38.80 /
ers-1 42.19 43.31 161.41 aspS 51.70 52.68 171.33
ers-3 66.31 67.90 82.72 cysS 11.25 10.08 100.07
frs-1 45.84 42.82 202.79 glnS 15.14 13.50 /
frs-2 45.84 42.82 192.17 glsS 29.17 29.46 /
grs-1 54.00 58.47 152.32 gltX 57.49 61.24 247.61
hrs-1 23.07 23.02 171.03 glyQS 74.08 75.48 /
irs-1 54.07 52.99 220.43 hisS 22.60 21.96 194.27
krs-1 62.82 64.24 323.80 ileS 56.77 58.95 129.04
lrs-1 85.16 82.34 143.51 leuS 105.96 100.77 322.29
mrs-1 32.17 29.52 185.49 lysU 45.30 51.79 /
nrs-1 48.44 47.32 231.11 metG 29.82 27.78 122.34
prs-1 49.64 51.17 221.29 pheS 38.24 37.15 288.63
rrt-1 52.05 52.84 199.94 pheT 38.24 37.15 299.49
srs-1 81.11 78.12 135.54 proS 44.19 42.67 29.79
trs-1 58.92 58.03 175.71 serS 57.76 54.97 /
vrs-2 62.44 63.35 146.32 thrS 54.00 53.40 457.90
wrs-1 10.87 10.42 / trpS 15.28 13.50 92.78
yrs-1 31.14 30.16 90.52 tyrS 28.02 27.25 /
valS 70.38 72.58 162.41
Table 4.9: The per mil frequencies of codons grouped by aminoacyl-tRNA
synthetase (codon bias by aaRS), the per mil frequencies of the expressed
codons grouped by aminoacyl-tRNA synthetase (codonome bias by aaRS), and
the aminoacyl-tRNA synthetases expression values in Danio rerio, Caenorhabditis
elegans, Saccharomyces cerevisiae and Escherichia coli. "/": value not found.
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4.2.2 Statistical analysis
The following results were exported in order to submit them to statistical analysis
using first default and then test calculations: a) codon bias, b) codonome bias, c)
codon bias grouped by aaRS, d) codonome bias grouped by aaRS, and e) the aaRS
expression values ("a", "b", "c" and "d" are expressed as per mil frequencies). Cor-
relation coefficients and p values for each comparison are listed in Table 4.10. See
Fig. 4.5 for human brain correlation graphs, Fig. 4.6 for human circulating blood
erythrocyte graphs, Fig. 4.7 for human DS-AMKL cells graphs and Fig. 4.8-4.11
for the other investigated species, D. rerio, C. elegans, S. cerevisiae and E. coli,
respectively.
The comparisons between the codon bias and the codonome bias, as well as
these values grouped by aaRS, show correlation coefficients very close to 1, with a
p value always < 0.0001, for all the investigated tissues and species. When random
and permuted numbers are used instead of human real expression values, the pattern
does not change; rather, the correlation coefficient is often even closer to 1.
When grouped by aaRS, codon bias and codonome bias, when compared to
aaRS mRNA expression values, show no correlation, with really low coefficients
(sometimes even negative ones), and p values of at least > 0.1 (p values at least >
0.05 only in the case of E. coli dataset), even when using random and permuted
expression values.
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Subset X variable Y variable (r) p value
Human brain a) codon bias b) codonome bias 0.996517 < 0.0001
c) codon bias by aaRS d) codonome bias by aaRS 0.999457 < 0.0001
c) codon bias by aaRS e) aaRS expression -0.022970 NS
d) codonome bias by aaRS e) aaRS expression -0.021290 NS
Human brain with a) codon bias b) codonome bias 0.996546 < 0.0001
absolute numbers instead c) codon bias by aaRS d) codonome bias by aaRS 0.999457 < 0.0001
of per mil frequencies c) codon bias by aaRS e) aaRS expression -0.051980 NS
d) codonome bias by aaRS e) aaRS expression -0.050950 NS
Human brain with a first a) codon bias b) codonome bias 0.999838 < 0.0001
permutation of the c) codon bias by aaRS d) codonome bias by aaRS 0.999937 < 0.0001
expression values c) codon bias by aaRS e) aaRS expression -0.024030 NS
d) codonome bias by aaRS e) aaRS expression -0.022320 NS
Second human brain with a a) codon bias b) codonome bias 0.999943 < 0.0001
second permutation of the c) codon bias by aaRS d) codonome bias by aaRS 0.999982 < 0.0001
expression values c) codon bias by aaRS e) aaRS expression -0.023000 NS
d) codonome bias by aaRS e) aaRS expression -0.023420 NS
Human brain with non- a) codon bias b) codonome bias 0.998791 < 0.0001
normalised expression c) codon bias by aaRS d) codonome bias by aaRS 0.999925 < 0.0001
values c) codon bias by aaRS e) aaRS expression -0.052180 NS
d) codonome bias by aaRS e) aaRS expression -0.050720 NS
Human brain with random a) codon bias b) codonome bias 0.999990 < 0.0001
expression values from c) codon bias by aaRS d) codonome bias by aaRS 0.999996 < 0.0001
1 to 104 c) codon bias by aaRS e) aaRS expression -0.052180 NS
d) codonome bias by aaRS e) aaRS expression -0.051980 NS
Human circulating a) codon bias b) codonome bias 0.979111 < 0.0001
blood erythrocytes c) codon bias by aaRS d) codonome bias by aaRS 0.998358 < 0.0001
c) codon bias by aaRS e) aaRS expression 0.119425 NS
d) codonome bias by aaRS e) aaRS expression 0.126501 NS
Human circulating blood a) codon bias b) codonome bias 0.998791 < 0.0001
erythrocytes with random c) codon bias by aaRS d) codonome bias by aaRS 0.937790 < 0.0001
expression values from c) codon bias by aaRS e) aaRS expression 0.074207 NS
1 to 105 d) codonome bias by aaRS e) aaRS expression 0.027150 NS
Human brain from patients a) codon bias b) codonome bias 0.990428 < 0.0001
affected by Trisomy 21 and c) codon bias by aaRS d) codonome bias by aaRS 0.996594 < 0.0001
Acute Megakaryoblastic c) codon bias by aaRS e) aaRS expression 0.015140 NS
Leukemia d) codonome bias by aaRS e) aaRS expression 0.041824 NS
Danio rerio brain a) codon bias b) codonome bias 0.986128 < 0.0001
c) codon bias by aaRS d) codonome bias by aaRS 0.992635 < 0.0001
c) codon bias by aaRS e) aaRS expression 0.384812 > 0.1743
d) codonome bias by aaRS e) aaRS expression 0.431892 > 0.1230
Caenorhabditis elegans a) codon bias b) codonome bias 0.979831 < 0.0001
c) codon bias by aaRS d) codonome bias by aaRS 0.991042 < 0.0001
c) codon bias by aaRS e) aaRS expression 0.026048 NS
d) codonome bias by aaRS e) aaRS expression 0.026811 NS
Saccharomyces cerevisiae a) codon bias b) codonome bias 0.991204 < 0.0001
c) codon bias by aaRS d) codonome bias by aaRS 0.996790 < 0.0001
c) codon bias by aaRS e) aaRS expression 0.224813 > 0.3698
d) codonome bias by aaRS e) aaRS expression 0.217939 > 0.3850
Escherichia coli a) codon bias b) codonome bias 0.988796 < 0.0001
c) codon bias by aaRS d) codonome bias by aaRS 0.996650 < 0.0001
c) codon bias by aaRS e) aaRS expression 0.510390 > 0,0519
d) codonome bias by aaRS e) aaRS expression 0.502108 > 0,0565
Table 4.10: Correlation coefficients (r) and p values of comparisons. a) The per mil
frequencies of codons (codon bias), b) the per mil frequencies of codons number
multiplied by expression value (codonome bias), c) the per mil frequencies of
codons grouped by aminoacyl-tRNA synthetase (codon bias by aaRS), d) the per
mil frequencies of real expressed codon grouped by aminoacyl-tRNA synthetase
(codonome bias by aaRS), e) the aminoacyl-tRNA synthetases mRNA expression
values (aaRS expression). NS, not significant.
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Figure 4.5: Correlation graphs in human brain. "a": the per mil frequencies of each
codon at genome level (codon bias); "b": the per mil frequencies of each codon
multiplied by expression value (codonome bias); "c": the per mil frequencies of
codons grouped by aminoacyl-tRNA synthetase (codon bias by aaRS); "d": the
per mil frequencies of real expressed codons grouped by aaRS (codonome bias by
aaRS); "e": the aaRS expression values. See Table 4.10 for correlation coefficients
and p values. The elliptic line represents the density ellipse at 0.50.
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Figure 4.6: Correlation graphs in human circulating blood erythrocytes. "a": the
per mil frequencies of each codon at genome level (codon bias); "b": the per mil
frequencies of each codon multiplied by expression value (codonome bias); "c": the
per mil frequencies of codons grouped by aminoacyl-tRNA synthetase (codon bias
by aaRS); "d": the per mil frequencies of real expressed codons grouped by aaRS
(codonome bias by aaRS); "e": the aaRS expression values. See Table 4.10 for
correlation coefficients and p values. The elliptic line represents the density ellipse
at 0.50.
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Figure 4.7: Correlation graphs in human Down Syndrome-related acute
megakaryoblastic leukemia cells. "a": the per mil frequencies of each codon at
genome level (codon bias); "b": the per mil frequencies of each codon multiplied by
expression value (codonome bias); "c": the per mil frequencies of codons grouped
by aminoacyl-tRNA synthetase (codon bias by aaRS); "d": the per mil frequencies
of real expressed codons grouped by aaRS (codonome bias by aaRS); "e": the aaRS
expression values. See Table 4.10 for correlation coefficients and p values. The
elliptic line represents the density ellipse at 0.50.
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Figure 4.8: Correlation graphs in Danio rerio brain. "a": the per mil frequencies
of each codon at genome level (codon bias); "b": the per mil frequencies of each
codon multiplied by expression value (codonome bias); "c": the per mil frequencies
of codons grouped by aminoacyl-tRNA synthetase (codon bias by aaRS); "d": the
per mil frequencies of real expressed codons grouped by aaRS (codonome bias by
aaRS); "e": the aaRS expression values. See Table 4.10 for correlation coefficients
and p values. The elliptic line represents the density ellipse at 0.50.
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Figure 4.9: Correlation graphs in Caenorhabditis elegans. "a": the per mil
frequencies of each codon at genome level (codon bias); "b": the per mil frequencies
of each codon multiplied by expression value (codonome bias); "c": the per mil
frequencies of codons grouped by aminoacyl-tRNA synthetase (codon bias by
aaRS); "d": the per mil frequencies of real expressed codons grouped by aaRS
(codonome bias by aaRS); "e": the aaRS expression values. See Table 4.10 for cor-
relation coefficients and p values. The elliptic line represents the density ellipse at
0.50.
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Figure 4.10: Correlation graphs in Saccharomices cerevisiae. "a": the per mil
frequencies of each codon at genome level (codon bias); "b": the per mil frequencies
of each codon multiplied by expression value (codonome bias); "c": the per mil
frequencies of codons grouped by aminoacyl-tRNA synthetase (codon bias by
aaRS); "d": the per mil frequencies of real expressed codons grouped by aaRS
(codonome bias by aaRS); "e": the aaRS expression values. See Table 4.10 for cor-
relation coefficients and p values. The elliptic line represents the density ellipse at
0.50.
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Figure 4.11: Correlation graphs in Escherichia coli. "a": the per mil frequencies
of each codon at genome level (codon bias); "b": the per mil frequencies of each
codon multiplied by expression value (codonome bias); "c": the per mil frequencies
of codons grouped by aminoacyl-tRNA synthetase (codon bias by aaRS); "d": the
per mil frequencies of real expressed codons grouped by aaRS (codonome bias by
aaRS); "e": the aaRS expression values. See Table 4.10 for correlation coefficients
and p values. The elliptic line represents the density ellipse at 0.50.
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4.3 Analysis of ASD implicated genes expression
4.3.1 ASD implicated genes
TargetScan prediction found, out of a total of 447 ASD implicated genes identified
from the available literature, 130 genes not having MREs for miR-ASD and 317
genes having at least one predicted MREs for miR-ASD. Among them, in healthy
and ASD considered samples from the first dataset [Voineagu et al., 2011], an ex-
pression value was available for 66 ASD-associated genes that do not have MREs
and 160 ASD-associated genes that have MREs. In fetal, child and adult samples
from the second dataset [Colantuoni et al., 2011], an expression value was available
for 114 ASD implicated genes that do not have MREs and 281 ASD implicated
genes that have MREs.
4.3.2 Statistical analysis
Median values of Pearson’s pairwise correlation coefficients and p values calculated
for ASD implicated genes without MREs for miR-ASD and for ASD implicated
genes with at least one MRE for miR-ASD for all the analysed data sets are listed
in Table 4.11.
Comparing these values using as a background the median values of Pearson’s
pairwise correlation coefficients calculated for all the 1000 permutations of ran-
domly picked genes not implicated with ASD, significant co-expression was found
for ASD implicated genes that share MREs for miR-ASD with MSNP1AS in healthy
and ASD affected adults (Fig. 4.12 and Fig. 4.13, respectively). During the normal
cortex development, a significant co-expression of ASD implicated genes was found
in child and adult samples (Fig. 4.14, Fig. 4.15, respectively) but not in fetal
samples (Fig. 4.16).
Considering the ASD implicated risk genotype in ASD affected adults, not sig-
nificant differences were found comparing the expression values of the two groups
of ASD implicated genes (Fig. 4.17).
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ASD implicated genes
without MREs with MREs
Median value p value Median value p value
Healthy adults 0.029 0.147 0.073 0.000
ASD affected adults 0.053 0.076 0.066 0.002
Healthy fetal samples 0.006 0.115 0.005 0.068
Healthy child samples 0.010 0.073 0.019 0.001
Healthy adults samples 0.006 0.080 0.018 0.000
Table 4.11: Median values of Pearson’s pairwise correlation coefficients. Pearson’s
pairwise correlation coefficients were calculated for expression values between all
the possible gene pairs in ASD implicated genes without and with MREs for miR-
ASD, respectively.
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Figure 4.12: Pearson’s pairwise correlation coefficients in healty adults. The arrows
represent the median value of coefficients for each group of autism associated genes:
ASD implicated genes without MREs for miR-ASD in red and ASD implicated
genes with at least one MRE for miR-ASD in blue. See Table 4.11 for median and
p values. The background is the median value of coefficients calculated for 1000
permutations of genes not implicated with ASD. pval: p value.
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Figure 4.13: Pearson’s pairwise correlation coefficients in ASD affected adults.
The arrows represent the median value of coefficients for each group of autism
associated genes: ASD implicated genes without MREs for miR-ASD in red and
ASD implicated genes with at least one MRE for miR-ASD in blue. See Table
4.11 for median and p values. The background is the median value of coefficients
calculated for 1000 permutations of genes not implicated with ASD. pval: p value.
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Figure 4.14: Pearson’s pairwise correlation coefficients in healthy child samples.
TThe arrows represent the median value of coefficients for each group of autism
associated genes: ASD implicated genes without MREs for miR-ASD in red and
ASD implicated genes with at least one MRE for miR-ASD in blue. See Table
4.11 for median and p values. The background is the median value of coefficients
calculated for 1000 permutations of genes not implicated with ASD. pval: p value.
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Figure 4.15: Pearson’s pairwise correlation coefficients in healthy adult samples.
The arrows represent the median value of coefficients for each group of autism
associated genes: ASD implicated genes without MREs for miR-ASD in red and
ASD implicated genes with at least one MRE for miR-ASD in blue. See Table
4.11 for median and p values. The background is the median value of coefficients
calculated for 1000 permutations of genes not implicated with ASD. pval: p value.
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Figure 4.16: Pearson’s pairwise correlation coefficients in healthy fetal samples.
The arrows represent the median value of coefficients for each group of autism
associated genes: ASD implicated genes without MREs for miR-ASD in red and
ASD implicated genes with at least one MRE for miR-ASD in blue. See Table
4.11 for median and p values. The background is the median value of coefficients
calculated for 1000 permutations of genes not implicated with ASD. pval: p value.
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Figure 4.17: Expression values of ASD implicated genes expressed in ASD samples
divided by genotype: AA is the genotype associated with ASD and with a higher
expression of MSNP1AS. For each genotype, ASD implicated genes without MREs
for miR-ASD are on the left and ASD implicated genes with at least one MRE for
miR-ASD on the right.
Chapter 5
Discussion
The late 1980s and early 1990s were fertile years thanks to the automation of se-
quencing techniques and to the computer spread. This period of fervent activity
gave rise to a flourishing number of new molecular structures and sequences and
to proliferation of new databases in which to store them. The public availabilty
of data is of an unestimated valour, because the collective use of data leads to the
discovery of new knowledge which goes beyond the results yielded by individual
experiments. In this work were presented three examples about the development of
new computational tools able to analyse the massive amount of publicly avalilable
data, which is often not completely exploited, in order to answer to important
biological questions. Each subject will be discuss in a separate section.
5.1 mRNA 5′ coding sequence
The continuous incorporation of information derived from individual and large-
scale cDNA sequencing projects (including those specifically designed to charac-
terise mRNA 5′ end [Carninci et al., 1996; Suzuki et al., 2000; Porcel et al., 2004])
in the last few years led to continuous improvement of completeness of mRNA
reference sequences (e.g., RefSeq), and also to the corresponding protein coding
sequences. However, genome browsers do not appear to systematically extract
useful information from the vast quantity of EST data. To date, EST data remain
invaluable due to significantly longer continuous RNA sequences they may provide
in comparison with the very short fragments typically deposited in current high-
throughput nucleotide sequencing databases. We first showed in zebrafish that EST
analysis by 5'_ORF_Extender software could extend the currently known mRNA
CDS [Frabetti et al., 2007], thereby differing from other methods, which do not
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incorporate prediction of the putative CDS extension (e.g., [Kitagawa et al., 2005]).
In this work, we have presented a modified strategy that was able to analyse
the much more numerous human sequences. Firstly, we fully revised the software
algorithm by using pre-computed coordinates of the UCSC-downloaded RefSeqs
and ESTs genome alignment data (rather than the results of a large scale BLAST
comparison), and specific UCSC-downloaded EST sequence entries. Rather than
GenBank EST raw entries, these are EST sequence entries in which nucleotides
which are unaligned to the genome are removed, and undetermined ("N") or mis-
matched nucleotides are replaced by the corresponding nucleotides present on the
genome. This key change significantly improved a number of areas: the soft-
ware speed of analysis, sensitivity (due to the implementation of management of
sequence in ’complement’ orientation with respect to the genome recorded DNA
strand, with consequent identification of previously undetected mRNA extensions
thank to ESTs in opposite orientation to the corresponding mRNA), specificity
(due to the use of EST sequence entries processed by UCSC as described above,
thereby avoiding false positive identification of start codons in the EST sequence,
and possibly false negatives too, thus further improving sensitivity), and usability
(due to the removal of all steps previously requiring Unix functions, such as local
running of BLAST and manipulations of large text files). Furthermore, we adopted
an original quality filter which was able to test if each single EST candidate with
sequence information of possible use for extending a known mRNA, was attributed
to the same locus of that mRNA by an updated, complete and embedded version of
UniGene. Lastly, we automated data summarisation for an analysed genome.
Following these improvements, 5'_ORF_Extender recognised a total of 477 loci,
out of the 18,665 human loci represented in the mRNA reference set, as bona fide
candidates for extension. The percentage of genes with an estimated incomplete
mRNA 5′coding sequence (2.6%) is in the lower range compared with previous
estimates (in the range of 2-5%), which were based on more limited samples of
sequences [Carninci et al., 1996; Suzuki et al., 2000; Porcel et al., 2004]. The
sensitivity of the method depends on the size of the EST repertoire available. Al-
though EST single-pass sequencing itself is prone to experimental errors, we strongly
suggest that the mRNAs for which more than one EST was found, deriving from two
independent cDNA libraries and leading to the same prediction, possess a longer
CDS than the one described so far.
The identification of the most upstream currently definable AUG start codon in
an mRNA sequence cannot itself formally exclude that in some cases a downstream
AUG codon may also be used by the ribosome, due to the phenomenon of alternative
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translation [Bazykin and Kochetov, 2011]. In addition, due to the availability of a
large number of tissue- or stage-specific EST data, the EST-based extended CDS
and/or the mRNA with the incomplete ORF could possibly derive from alternative
transcription starting sites and/or splicing at the investigated locus. Nevertheless,
the protein-coding nature of additional nucleotides at the 5′ of the locus is high-
lighted, and in the results each distinct alternative RefSeq mRNA isoform mapping
to the same locus is associated only with the EST-based extended CDS with which
it is compatible.
As a proof-of-concept, we have experimentally confirmed the EST-based models
showing an extended coding region at 5′ end for three randomly chosen mRNAs:
GNB2L1 (guanine nucleotide binding protein (G protein), beta polypeptide 2-like
1), QARS (glutaminyl-tRNA synthetase) and TDP2 (tyrosyl-DNA phosphodiesterase
2) (Table 3.1). In these three cases, cross-species comparison at amino acid level
indicated a very high grade of conservation of the extended sequence among pri-
mates (Fig. 4.4). Therefore, the predicted product for these three human genes
should be redefined for functional studies.
GNB2L1 (located on 5q35.3), also known as RACK1 (Receptor for activated
C-kinase 1), is an ubiquitously expressed gene encoding a protein, homologous
to the G protein ß subunit, which can coordinate the interaction of a variety of
key signaling molecules. It is believed to play a central role in many biological
processes (cell growth, translation, apoptosis, migration, cell cycle, cell division)
[McCahill et al., 2002]. Interestingly, while in interaction studies this protein was
retrieved as a prey starting from many other proteins as a bait (interactions listed
in the Entrez Gene entry at: http://www.ncbi.nlm.nih.gov/gene/10399), to date no
study appears to have been designed using GNB2L1 as a bait. Such a study could
have the advantage of expressing a more complete product for GNB2L1, including
78 amino acids at its amino terminus (Fig. 4.4A), which could reveal additional
interactions compared with the product encoded by the currently known cDNA. For
example, when Fomenkov et al. [Fomenkov et al., 2004] reported the extension of
the interacting GNB2L1 cDNA CDS, it appeared not to include the region described
here, and the interaction was localised to the C-terminal region of GNB2L1 protein.
Notably, our analysis also identifies an in-frame stop codon upstream of the newly
determined GNB2L1 start codon. This would suggest that the extended coding
region at 5´ for this mRNA is now complete, since the use of possibly existent fur-
ther start codons would hesitate in translation stopping upstream of the translation
start in the correct frame.
The QARS gene maps on 3p21.31 and encodes an aminoacyl-tRNA synthetase.
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Functional data are summarised at the Entrez Gene entry:
http://www.ncbi.nlm.nih.gov/gene/5859. The QARS cDNA was used in at least
one study of human protein-protein pair wise interaction [Rual et al., 2005] and
it was derived from human ORFeome v1.1 database [Rual et al., 2004], which, in
its current 5.1 version (http://horfdb.dfci.harvard.edu/), still lacks codons we have
determined here by cDNA sequencing. In fact, in the ORFeome, the cDNA clones
from which the QARS ORF was deduced reported only few bases upstream of the
putative start codon, thus hampering the individuation of further in-frame upstream
codons, which were instead identified by our EST-based analysis. Although, in
this case, the extra amino acids are few (Fig. 4.4B), making unlikely significant
changes in the interaction study, this finding stresses the need for gene annotation
refinements. As in the case of GNB2L1, the presence of an in-frame stop codon
upstream of the newly determined QARS start codon suggests that the extended
coding region at 5′ for this mRNA is now complete (Fig. 4.3.
The TDP2 gene, located on 6p22.3-p22.1, encodes a member of a superfamily
of divalent cation-dependent phosphodiesterases and also has several interactions
described summarised at the Entrez Gene entry:
http://www.ncbi.nlm.nih.gov/gene/51567, where its cDNA was not used as a bait.
Its known CDS appears to lack 30 conserved amino acids corresponding to the
protein amino terminus (Fig. 4.4C).
5.2 Codon bias
Codon bias is a well-known phenomenon, observed in species from bacteria to
mammals. Preferred codons can differ dramatically between species and also within
a genome. The direct application of this phenomenon is usually the optimisation of
the heterolog expression of a protein exploiting the codon bias of the guest. It has
been demonstrated that the use of particular codons can increase the expression of
a transgene by over 1,000-fold [Gustafsson et al., 2004].
However, codon bias is often studied among few genes, and always at the genome
level. Here we have presented a computational system capable of studying codon
bias in a new way. We developed software useful for studying codon bias at mRNA
level, which counts each time that a given codon is represented in the transcriptome,
thus accounting for the abundance of each mRNA bearing that codon (Fig. 3.2).
We refer to the total number of codons (n) present across all the mRNAs pool,
each expressed at a certain level (x) in a given biological condition as its codonome
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value (cv = ∑(n × x) for the mRNAs pool). This is an entirely new concept in
genomics, which allows us to determine the consistence of the actual pool of codons
physically existent in the mRNA space of a cell, rather than the codon frequency
at the level of the gene sequence. The innovative "CODONOME" software is
able to calculate these parameters, offering the possibility to test whether there are
limits that constrain representation of a codon in the whole transcriptome given
its frequency at the genome level (codon bias). We used as reference data input
gene expression profiles calculated by integration and normalisation of different
datasets for a given tissue, following the demonstration that this approach gives a
more accurate representation of a reference transcriptome as compared to the use
of platform- or experimental-skewed datasets [Lenzi et al., 2011]. As expected, the
normalised expression profiles show that the genes with the highest expression val-
ues are housekeeping genes (see Table 4.2 and Table 4.3). In addition, the human
circulating blood erythrocytes expression profile highlights the preponderance of
the most frequently expressed hemoglobin subunits. These findings emphasise the
consistence of the reference gene expression profiles we have calculated with the
known biology of the considered tissues.
In addition, the "CODONOME" software may show the codons grouped in
relation to the aaRS that recognise each group, to explore whether cells organised
in such a way optimise the translation process, expressing preferentially aaRS that
recognise most frequent codons.
Our findings highlight some new concepts of general relevance about the rela-
tionship between the codon bias at genome level and the transcriptome output in
term of pool of codons.
First, we demonstrate a surprisingly tight correlation (r > 0.97, with the excep-
tion of a single case with r > 0.93) between the frequency of each codon at genome
level (codon bias) and the proportion of that codon in the transcriptome (codonome
bias) in different human tissues. This is not trivial because, due to the highly skewed
representation of particular gene subsets in various differentiated tissues and to
codon bias alteration in singular gene sequence, a more or less relevant loss of cor-
relation could be expected. It seems that a global compensation may exist between
codon bias of highly and of poorly expressed genes, even in extremely differentiated
tissues with a remarkable expression preponderance of a small number of proteins,
as we found in human circulating blood erythrocytes analysis.
Moreover, this high correlation level is maintained across multiple species, from
bacteria to humans. This finding clearly implies that the proportional represen-
tation of each codon in the DNA and mRNA pool is a general law of nature. It
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is reasonable to hypothesise that this correlation, resulting from the interaction
of the gene number, the skewing of genome codon bias for each gene, and the
allowed gene expression value range, allows for a maximal optimisation of the
transcription and translation processes. Indeed, replacement of actual expression
values by random numbers in different ranges shows that the universal law of cor-
relation between codon bias and codonome at a genome scale is not limited to the
real gene subsets expressed in nature, but emerges as a general property of the
distribution and range of the number, sequence, and expression level of the genes
included in a genome. This also implies the important conclusion that there is no
constraint, in terms of codon bias, for the global distribution of gene expression
values during transcription of a genome.
An additional key finding of this study is the demonstration that the codon
bias/codonome correlation is not disrupted by a profound alteration of normal gene
expression profile such as may be found in aneuploidy or cancer. We tested the
transcriptome of DS-AMKL cells, a condition grouping an aneuplody state with a
cancer state, and confirmed the universal value of this correlation.
On the other hand, we found no correlation between aaRS mRNA level expres-
sion and their respective recognised codons in the codonome, so it would seem that
cells do not use this process to optimise the translation. The explanation may be that
aaRS, essential enzymes, are usually in molar excess in the translation machinery
and that fine-tuning of their expression in relation to the codonome to be translated
is not needed. An alternative explanation could be a tuning of an aaRS expression
at translation level of their mRNAs rather than at the transcription level investigated
here.
5.3 ASD implicated genes
Autism spectrum disorder (ASD) is a highly heritable and complex neurodevelop-
mental condition that results in behavioral, social and communication impairments.
The genetic complexity of this disorder is underlined by the fact that despite exten-
sive efforts to elucidate the causes of ASD uncovering hundreds of susceptibility
loci and candidate genes, only a few of these markers represent clear targets for
further analyses.
Our analyses were aimed to find a common network in which ASD candidate
genes act in tune leading to the disorder development. Recent publications have
shown that endogenous transcripts, both coding and non coding, sharing microRNA
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response elements (MREs) for the same microRNA can influence the expression
level of each other through competitive microRNA binding. As a long non coding
RNA, MSNP1AS, been recently identified associated with ASD and the increased
ASD risk genotype, has four MREs for a microRNA, we think that it could regulate
the expression of ASD implicated genes by competing with them for the microRNA
binding. Our prediction shows indeed that 70.9% of ASD candidate genes, out of
all genes identified to be implicated with ASD from the literature, share at least one
MRE for the same microRNA with MSNP1AS. Our computational analyses con-
firmed that only ASD implicated genes sharing at least one MREs with MSNP1AS
for the same microRNA are more co-expressed in the prefrontal cortex than expected
by chance, in both healty and ASD affected adults. ASD implicated genes are as
well co-expressed in both healthy children and healthy adults, but this association
was not found in analysed fetal samples, confirming gene expression changes during
the normal brain development [Colantuoni et al., 2011] and suggesting a possible
role of ASD implicated genes regulated by MSNP1AS during the pathology devel-
opment. ASD implicated genes without any MRE for the microRNA never show
significant p values, which indicates that these genes are not involved in the network
with MSNP1AS.
Considering the ASD risk genotype, if MSNP1AS is highly expressed, competing
for the microRNA binding with the ASD implicated genes, it would lead to a over
expression of the ASD implicated genes because less microRNA molecules are
available to bind (and thus to regulate) them. This is not what we observed, because
we are not able to find differences in ASD implicated genes’ expression in the ASD
increased risk genotype.
The proportion of the population with ASD that has been sampled to date is
limited and not accurate. Further analyses should be conducted with a greater
number of samples with known genotype and of a better RNA quality, grouped
by sex and age and from different brain regions. Furthermore in vitro and in vivo
experiments are needed to study the over and the under expression of MSNP1AS and
their consequences in the abundance of the microRNA and of the ASD implicated
genes, in order to test the hypothesis of a network in wich MSNP1AS regulates ASD
implicated genes.
Conclusions
In conclusion, in this study we have presented three different computational biology
approaches useful in order to study the structure, as in the case of mRNA 5′ coding
region sequence, and expression, as in case of the codonome bias and the ASD
implicated genes, of human genes.
Our first approach has been able to generate, on a genome scale, 477 EST-driven
original extended CDSs of human mRNAs, which are now available to researchers
interested in these loci. In addition, software users can access a list of 20,775 human
mRNAs in which the presence of an in-frame stop codon upstream of the known
start codon indicates completeness of the coding sequence at 5′ in the current form.
In the second section we presented a novel biological concept in genomics,
the codonome, indicating the codon pool in the mRNA molecules of a cell. We
have also developed a freely available software program, "CODONOME", which is
able to calculate the parameters connected to codon bias and codonome concepts.
Systematic analysis across multiple tissues, species, and conditions shows that rep-
resentation of codon bias in the transcriptome (codonome) is tightly linked to the
genome bias at codon level, and that codon bias/codonome correlation is a general
property of natural genomes.
Lastly, the third approach is useful to study the expression of human genes. We
have found the existence of a network in which autism spectrum disorder implicated
genes sharing microRNA response elements for the same microRNA are co-ex-
pressed. We think that changes in the expression of a recently identified long non
coding RNA which have four microRNA response elements for the same microRNA
can regulate the expression of these genes disrupting the equilibrium in this network,
but further analyses and experiments are needed.
These three examples showed how the massive amount of publicly available
data are of an unestimated valour being still useful to study biological processes,
sometimes even different from the purpose for which they have been created.
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